0000850429 12/31 2022 Q1 FALSE 0000850429 2022-01-01 2022-03-31 0000850429 2022-04-29 xbrli:shares 0000850429 2022-03-31 iso4217:USD 0000850429 2021-12-31 0000850429 2021-01-01 2021-03-31 0000850429 us-gaap:ProductMember 2022-01-01 2022-03-31 0000850429 us-gaap:ProductMember 2021-01-01 2021-03-31 0000850429 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-03-31 0000850429 us-gaap:ShippingAndHandlingMember 2021-01-01 2021-03-31 iso4217:USD xbrli:shares 0000850429 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000850429 2020-12-31 0000850429 2021-03-31 0000850429 us-gaap:CommonStockMember 2021-12-31 0000850429 us-gaap:RetainedEarningsMember 2021-12-31 0000850429 tg:TrustForSavingRestorationPlanMember 2021-12-31 0000850429 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000850429 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000850429 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000850429 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000850429 tg:TrustForSavingRestorationPlanMember 2022-01-01 2022-03-31 0000850429 us-gaap:CommonStockMember 2022-03-31 0000850429 us-gaap:RetainedEarningsMember 2022-03-31 0000850429 tg:TrustForSavingRestorationPlanMember 2022-03-31 0000850429 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000850429 us-gaap:CommonStockMember 2020-12-31 0000850429 us-gaap:RetainedEarningsMember 2020-12-31 0000850429 tg:TrustForSavingRestorationPlanMember 2020-12-31 0000850429 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000850429 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000850429 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000850429 tg:TrustForSavingRestorationPlanMember 2021-01-01 2021-03-31 0000850429 us-gaap:CommonStockMember 2021-03-31 0000850429 us-gaap:RetainedEarningsMember 2021-03-31 0000850429 tg:TrustForSavingRestorationPlanMember 2021-03-31 0000850429 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000850429 us-gaap:PensionPlansDefinedBenefitMember 2022-02-09 2022-02-09 0000850429 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-03-31 0000850429 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000850429 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-01-01 2022-03-31 0000850429 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-03-31 0000850429 tg:AccruedExpensesMember 2022-03-31 0000850429 tg:KaleoMember 2022-01-01 2022-03-31 0000850429 tg:KaleoMember 2021-01-01 2021-03-31 0000850429 tg:HarbingerCapitalPartnersSpecialSituationsFundMember 2022-01-01 2022-03-31 0000850429 tg:HarbingerCapitalPartnersSpecialSituationsFundMember 2021-01-01 2021-03-31 0000850429 tg:HarbingerCapitalPartnersSpecialSituationsFundMember 2022-03-31 0000850429 tg:HarbingerCapitalPartnersSpecialSituationsFundMember 2021-12-31 0000850429 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0000850429 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0000850429 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0000850429 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-03-31 0000850429 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-03-31 0000850429 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-03-31 0000850429 us-gaap:AccumulatedTranslationAdjustmentMember 2022-03-31 0000850429 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-03-31 0000850429 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-03-31 0000850429 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000850429 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0000850429 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000850429 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0000850429 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-03-31 0000850429 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-03-31 0000850429 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0000850429 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-03-31 0000850429 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-03-31 0000850429 tg:AluminumFuturesContractsMember 2022-03-31 tg:lbs 0000850429 tg:AluminumFuturesContractsMember 2021-12-31 0000850429 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember tg:AluminumFuturesContractsMember 2022-03-31 0000850429 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember tg:AluminumFuturesContractsMember 2021-12-31 0000850429 us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember tg:AluminumFuturesContractsMember 2022-03-31 0000850429 us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember tg:AluminumFuturesContractsMember 2021-12-31 0000850429 tg:AccruedExpensesMember us-gaap:DesignatedAsHedgingInstrumentMember tg:AluminumFuturesContractsMember 2022-03-31 0000850429 tg:AccruedExpensesMember us-gaap:DesignatedAsHedgingInstrumentMember tg:AluminumFuturesContractsMember 2021-12-31 0000850429 tg:TerphaneLtdaMember tg:Oct2018Member 2022-01-01 2022-03-31 iso4217:BRL 0000850429 tg:TerphaneLtdaMember tg:Apr22Member 2022-03-31 xbrli:pure 0000850429 tg:TerphaneLtdaMember tg:May22Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Jun22Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Jul22Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Aug22Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Sep22Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Oct22Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Nov22Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Dec22Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Jan23Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Feb23Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Mar23Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Apr23Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:May23Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Jun23Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Jul23Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Aug23Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Sep23Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Oct23Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Nov23Member 2022-03-31 0000850429 tg:TerphaneLtdaMember tg:Dec23Member 2022-03-31 0000850429 tg:TerphaneLtdaMember 2022-03-31 0000850429 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2022-03-31 0000850429 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2021-12-31 0000850429 us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-03-31 0000850429 us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000850429 tg:AccruedExpensesMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-03-31 0000850429 tg:AccruedExpensesMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000850429 us-gaap:CostOfSalesMember us-gaap:CashFlowHedgingMember tg:AluminumFuturesContractsMember 2022-01-01 2022-03-31 0000850429 us-gaap:CostOfSalesMember us-gaap:CashFlowHedgingMember tg:AluminumFuturesContractsMember 2021-01-01 2021-03-31 0000850429 us-gaap:CostOfSalesMember us-gaap:CashFlowHedgingMember tg:ForeignCurrencyForwardsAndOptionsMember 2022-01-01 2022-03-31 0000850429 us-gaap:CashFlowHedgingMember tg:ForeignCurrencyForwardsAndOptionsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-03-31 0000850429 us-gaap:CostOfSalesMember us-gaap:CashFlowHedgingMember tg:ForeignCurrencyForwardsAndOptionsMember 2021-01-01 2021-03-31 0000850429 us-gaap:CashFlowHedgingMember tg:ForeignCurrencyForwardsAndOptionsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-03-31 0000850429 tg:BrazilianMember 2022-01-01 2022-03-31 0000850429 tg:TerphaneLtdaMember 2022-01-01 2022-03-31 0000850429 tg:AluminumExtrusionsMember 2022-01-01 2022-03-31 0000850429 tg:AluminumExtrusionsMember 2021-01-01 2021-03-31 0000850429 tg:PEFilmsMember 2022-01-01 2022-03-31 0000850429 tg:PEFilmsMember 2021-01-01 2021-03-31 0000850429 tg:FlexiblePackagingFilmsMemberDomain 2022-01-01 2022-03-31 0000850429 tg:FlexiblePackagingFilmsMemberDomain 2021-01-01 2021-03-31 0000850429 tg:FlexiblePackagingFilmsMember 2022-01-01 2022-03-31 0000850429 tg:FlexiblePackagingFilmsMember 2021-01-01 2021-03-31 0000850429 tg:AluminumExtrusionsMember 2022-03-31 0000850429 tg:AluminumExtrusionsMember 2021-12-31 0000850429 tg:PEFilmsMember 2022-03-31 0000850429 tg:PEFilmsMember 2021-12-31 0000850429 tg:FlexiblePackagingFilmsMember 2022-03-31 0000850429 tg:FlexiblePackagingFilmsMember 2021-12-31 0000850429 tg:SubtotalMember 2022-03-31 0000850429 tg:SubtotalMember 2021-12-31 0000850429 tg:GeneralCorporateMember 2022-03-31 0000850429 tg:GeneralCorporateMember 2021-12-31 0000850429 country:US 2022-01-01 2022-03-31 0000850429 country:US 2021-01-01 2021-03-31 0000850429 srt:AsiaMember tg:ExportsFromUnitedStatesMember 2022-01-01 2022-03-31 0000850429 srt:AsiaMember tg:ExportsFromUnitedStatesMember 2021-01-01 2021-03-31 0000850429 srt:LatinAmericaMember tg:ExportsFromUnitedStatesMember 2022-01-01 2022-03-31 0000850429 srt:LatinAmericaMember tg:ExportsFromUnitedStatesMember 2021-01-01 2021-03-31 0000850429 country:CA tg:ExportsFromUnitedStatesMember 2022-01-01 2022-03-31 0000850429 country:CA tg:ExportsFromUnitedStatesMember 2021-01-01 2021-03-31 0000850429 srt:EuropeMember tg:ExportsFromUnitedStatesMember 2022-01-01 2022-03-31 0000850429 srt:EuropeMember tg:ExportsFromUnitedStatesMember 2021-01-01 2021-03-31 0000850429 tg:OperationsOutsideUnitedStatesMember country:BR 2022-01-01 2022-03-31 0000850429 tg:OperationsOutsideUnitedStatesMember country:BR 2021-01-01 2021-03-31 0000850429 tg:AluminumExtrusionsMember tg:NonresidentialBuildingAndConstructionMember 2022-01-01 2022-03-31 0000850429 tg:AluminumExtrusionsMember tg:NonresidentialBuildingAndConstructionMember 2021-01-01 2021-03-31 0000850429 tg:AluminumExtrusionsMember tg:ConsumerDurablesMember 2022-01-01 2022-03-31 0000850429 tg:AluminumExtrusionsMember tg:ConsumerDurablesMember 2021-01-01 2021-03-31 0000850429 tg:AluminumExtrusionsMember tg:AutomotiveMember 2022-01-01 2022-03-31 0000850429 tg:AluminumExtrusionsMember tg:AutomotiveMember 2021-01-01 2021-03-31 0000850429 tg:ResidentialBuildingAndConstructionMember tg:AluminumExtrusionsMember 2022-01-01 2022-03-31 0000850429 tg:ResidentialBuildingAndConstructionMember tg:AluminumExtrusionsMember 2021-01-01 2021-03-31 0000850429 tg:AluminumExtrusionsMember tg:ElectricalMember 2022-01-01 2022-03-31 0000850429 tg:AluminumExtrusionsMember tg:ElectricalMember 2021-01-01 2021-03-31 0000850429 tg:MachineryandEquipmentBNLDomain tg:AluminumExtrusionsMember 2022-01-01 2022-03-31 0000850429 tg:MachineryandEquipmentBNLDomain tg:AluminumExtrusionsMember 2021-01-01 2021-03-31 0000850429 tg:AluminumExtrusionsMember tg:DistributionMember 2022-01-01 2022-03-31 0000850429 tg:AluminumExtrusionsMember tg:DistributionMember 2021-01-01 2021-03-31 0000850429 tg:AluminumExtrusionsMember tg:AluminumExtrusionsSubtotalMember 2022-01-01 2022-03-31 0000850429 tg:AluminumExtrusionsMember tg:AluminumExtrusionsSubtotalMember 2021-01-01 2021-03-31 0000850429 tg:PEFilmsMember tg:SurfaceProtectionFilmsMember 2022-01-01 2022-03-31 0000850429 tg:PEFilmsMember tg:SurfaceProtectionFilmsMember 2021-01-01 2021-03-31 0000850429 tg:PEFilmsMember tg:OverwrapPackagingMember 2022-01-01 2022-03-31 0000850429 tg:PEFilmsMember tg:OverwrapPackagingMember 2021-01-01 2021-03-31 0000850429 tg:FilmProductsSubtotalMember tg:PEFilmsMember 2022-01-01 2022-03-31 0000850429 tg:FilmProductsSubtotalMember tg:PEFilmsMember 2021-01-01 2021-03-31 0000850429 2020-08-24 0000850429 tg:KaleoMember 2008-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022
OR

¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to
Commission file number 1-10258

Tredegar Corporation
(Exact Name of Registrant as Specified in Its Charter)

Virginia |  | 54-1497771
(State or Other Jurisdiction of Incorporation or Organization) |  | (I.R.S. Employer Identification No.)

1100 Boulders Parkway |  |
Richmond, | Virginia |  | 23225
(Address of Principal Executive Offices) |  | (Zip Code)

Registrant’s Telephone Number, Including Area Code: (804) 330-1000
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common stock, no par value | TG | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer |  | ¨ | Accelerated filer | x | Smaller reporting company |  | ☐
Non-accelerated filer |  | ¨ |  | Emerging growth company |  | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x
The number of shares of Common Stock, no par value, outstanding as of April 29, 2022: 33,853,082

Tredegar Corporation
Table of Contents

|  | Page
Part I | Financial Statements |  | 2
Item 1. | Condensed Consolidated Balance Sheets (unaudited) |  | 2
| Condensed Consolidated Statements of Income (Loss) (unaudited) |  | 3
| Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited) |  | 4
| Condensed Consolidated Statements of Cash Flows (unaudited) |  | 5
| Condensed Consolidated Statements of Shareholders' Equity (unaudited) |  | 6
| Notes to the Condensed Consolidated Financial Statements (unaudited) |  | 7
Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations |  | 17
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |  | 28
Item 4. | Controls and Procedures |  | 32
Part II | Other Information |  | 34
Item 1A. | Risk Factors |  | 34
Item 6. | Exhibits |  | 35

PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
Tredegar Corporation
Condensed Consolidated Balance Sheets
(In Thousands, Except Share Data)
(Unaudited)

| March 31, |  | December 31,
| 2022 |  | 2021
Assets |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 25,648 |  |  | $ | 30,521 |
Accounts and other receivables, net | 129,559 |  |  | 103,312 |
Income taxes recoverable | 2,512 |  |  | 2,558 |
Inventories | 104,560 |  |  | 88,569 |
Prepaid expenses and other | 17,183 |  |  | 11,275 |
Current assets of discontinued operations | 151 |  |  | 178 |
Total current assets | 279,613 |  |  | 236,413 |
Property, plant and equipment, at cost | 506,511 |  |  | 498,311 |
Less: accumulated depreciation | (333,944) |  |  | (327,930) |
Net property, plant and equipment | 172,567 |  |  | 170,381 |
Right-of-use leased assets | 13,385 |  |  | 13,847 |
Identifiable intangible assets, net | 13,632 |  |  | 14,152 |
Goodwill | 70,608 |  |  | 70,608 |
Deferred income taxes | 11,409 |  |  | 15,723 |
Other assets | 3,457 |  |  | 2,460 |
Total assets | $ | 564,671 |  |  | $ | 523,584 |
Liabilities and Shareholders’ Equity |  |  |
Current liabilities: |  |  |
Accounts payable | $ | 144,585 |  |  | $ | 123,760 |
Accrued expenses | 27,012 |  |  | 33,104 |
Lease liability, short-term | 2,119 |  |  | 2,158 |
Income taxes payable | 643 |  |  | 9,333 |
Current liabilities of discontinued operations | 178 |  |  | 193 |
Total current liabilities | 174,537 |  |  | 168,548 |
Lease liability, long-term | 12,361 |  |  | 12,831 |
Long-term debt | 131,250 |  |  | 73,000 |
Pension and other postretirement benefit obligations, net | 28,333 |  |  | 78,265 |
Other non-current liabilities | 6,322 |  |  | 6,218 |
Total liabilities | 352,803 |  |  | 338,862 |
Shareholders’ equity: |  |  |
Common stock, no par value (issued and outstanding 33,837,815 shares at March 31, 2022 and 33,736,629 shares at December 31, 2021) | 55,953 |  |  | 55,174 |
Common stock held in trust for savings restoration plan (109,494 shares at March 31, 2022 and 108,433 shares at December 31, 2021) | (2,148) |  |  | (2,135) |
Accumulated other comprehensive income (loss): |  |  |
Foreign currency translation adjustment | (80,256) |  |  | (85,792) |
Gain (loss) on derivative financial instruments | 6,831 |  |  | 901 |
Pension and other postretirement benefit adjustments | (62,075) |  |  | (64,613) |
Retained earnings | 293,563 |  |  | 281,187 |
Total shareholders’ equity | 211,868 |  |  | 184,722 |
Total liabilities and shareholders’ equity | $ | 564,671 |  |  | $ | 523,584 |

See accompanying notes to financial statements.
2

Tredegar Corporation
Condensed Consolidated Statements of Income (Loss)
(In Thousands, Except Per Share Data)
(Unaudited)

|  |  | Three Months Ended March 31,
|  |  |  |  | 2022 |  | 2021
Revenues and other items: |  |  |  |  |  |  |
Sales |  |  |  |  | $ | 236,566 |  |  | $ | 184,822 |
Other income (expense), net |  |  |  |  | (267) |  |  | 760 |
|  |  |  |  | 236,299 |  |  | 185,582 |
Costs and expenses: |  |  |  |  |  |  |
Cost of goods sold |  |  |  |  | 183,260 |  |  | 141,285 |
Freight |  |  |  |  | 8,081 |  |  | 6,223 |
Selling, general and administrative |  |  |  |  | 21,282 |  |  | 18,384 |
Research and development |  |  |  |  | 1,525 |  |  | 1,721 |
Amortization of identifiable intangibles |  |  |  |  | 663 |  |  | 723 |
Pension and postretirement benefits |  |  |  |  | 3,476 |  |  | 3,540 |
Interest expense |  |  |  |  | 786 |  |  | 822 |
Asset impairments and costs associated with exit and disposal activities, net of adjustments |  |  |  |  | (9) |  |  | 169 |
Total |  |  |  |  | 219,064 |  |  | 172,867 |
Income (loss) from continuing operations before income taxes |  |  |  |  | 17,235 |  |  | 12,715 |
Income tax expense (benefit) |  |  |  |  | 778 |  |  | 3,097 |
Net income (loss) from continuing operations |  |  |  |  | 16,457 |  |  | 9,618 |
Income (loss) from discontinued operations, net of tax |  |  |  |  | (35) |  |  | (587) |
Net income (loss) |  |  |  |  | $ | 16,422 |  |  | $ | 9,031 |
Earnings (loss) per share: |  |  |  |  |  |  |
Basic: |  |  |  |  |  |  |
Continuing operations |  |  |  |  | $ | 0.49 |  |  | $ | 0.29 |
Discontinued operations |  |  |  |  | — |  |  | (0.02) |
Basic earnings (loss) per share |  |  |  |  | $ | 0.49 |  |  | $ | 0.27 |
Diluted: |  |  |  |  |  |  |
Continuing operations |  |  |  |  | $ | 0.49 |  |  | $ | 0.29 |
Discontinued operations |  |  |  |  | — |  |  | (0.02) |
Diluted earnings (loss) per share |  |  |  |  | $ | 0.49 |  |  | $ | 0.27 |
Shares used to compute earnings (loss) per share: |  |  |  |  |  |  |
Basic |  |  |  |  | 33,654 |  |  | 33,406 |
Diluted |  |  |  |  | 33,696 |  |  | 33,644 |

See accompanying notes to financial statements.
3

Tredegar Corporation
Condensed Consolidated Statements of Comprehensive Income (Loss)
(In Thousands)
(Unaudited)

| Three Months Ended March 31,
| 2022 |  | 2021
Net income (loss) | $ | 16,422 |  |  | $ | 9,031 |
Other comprehensive income (loss): |  |  |
Unrealized foreign currency translation adjustment (net of tax expense of $728 in 2022 and net of tax benefit of $272 in 2021) | 5,536 |  |  | (2,648) |
Derivative financial instruments adjustment (net of tax expense of $2,916 in 2022 and net of tax benefit of $188 in 2021) | 5,930 |  |  | (236) |
Amortization of prior service costs and net gains or losses (net of tax expense of $712 in 2022 and net of tax of $924 in 2021) | 2,538 |  |  | 3,319 |
Other comprehensive income (loss) | 14,004 |  |  | 435 |
Comprehensive income (loss) | $ | 30,426 |  |  | $ | 9,466 |

See accompanying notes to financial statements.
4

Tredegar Corporation
Condensed Consolidated Statements of Cash Flows
(In Thousands)
(Unaudited)

| Three Months Ended March 31,
| 2022 |  | 2021
Cash flows from operating activities: |  |  |
Net income (loss) | $ | 16,422 |  |  | $ | 9,031 |
Adjustments for noncash items: |  |  |
Depreciation | 5,829 |  |  | 5,463 |
Amortization of identifiable intangibles | 663 |  |  | 723 |
Reduction of right-of-use lease asset | 500 |  |  | 549 |
Deferred income taxes | 552 |  |  | 1,017 |
Accrued pension and post-retirement benefits | 3,506 |  |  | 3,540 |
Stock-based compensation expense | 1,295 |  |  | 576 |
Gain on investment in kaléo | — |  |  | (400) |
Changes in assets and liabilities: |  |  |
Accounts and other receivables | (24,351) |  |  | (2,126) |
Inventories | (12,622) |  |  | (5,442) |
Income taxes recoverable/payable | (8,791) |  |  | 1,102 |
Prepaid expenses and other | 3,323 |  |  | 2,798 |
Accounts payable and accrued expenses | 10,384 |  |  | (2,517) |
Lease liability | (547) |  |  | (535) |
Pension and postretirement benefit plan contributions | (50,158) |  |  | (3,886) |
Other, net | (742) |  |  | (23) |
Net cash (used in) provided by operating activities | (54,737) |  |  | 9,870 |
Cash flows from investing activities: |  |  |
Capital expenditures | (5,086) |  |  | (5,259) |
Net cash used in investing activities | (5,086) |  |  | (5,259) |
Cash flows from financing activities: |  |  |
Borrowings | 109,500 |  |  | 32,000 |
Debt principal payments | (51,250) |  |  | (23,000) |
Dividends paid | (4,059) |  |  | (4,025) |
Other | (396) |  |  | 915 |
Net cash provided by financing activities | 53,795 |  |  | 5,890 |
Effect of exchange rate changes on cash | 1,155 |  |  | (488) |
Increase (decrease) in cash & cash equivalents | (4,873) |  |  | 10,013 |
Cash and cash equivalents at beginning of period | 30,521 |  |  | 11,846 |
Cash and cash equivalents at end of period | $ | 25,648 |  |  | $ | 21,859 |

See accompanying notes to financial statements.
5

Tredegar Corporation
Condensed Consolidated Statements of Shareholders’ Equity
(In Thousands, Except Share and Per Share Data)
(Unaudited)
The following summarizes the changes in shareholders’ equity for the three month period ended March 31, 2022:

| Common Stock |  | Retained Earnings |  | Trust for Savings Restoration Plan |  | Accumulated Other Comprehensive Income (Loss) |  | Total Shareholders’ Equity
Balance January 1, 2022 | $ | 55,174 |  |  | $ | 281,187 |  |  | $ | (2,135) |  |  | $ | (149,504) |  |  | $ | 184,722 |
Net income (loss) | — |  |  | 16,422 |  |  | — |  |  | — |  |  | 16,422 |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | 5,536 |  |  | 5,536 |
Derivative financial instruments adjustment | — |  |  | — |  |  | — |  |  | 5,930 |  |  | 5,930 |
Amortization of prior service costs and net gains or losses | — |  |  | — |  |  | — |  |  | 2,538 |  |  | 2,538 |
Cash dividends declared ($0.12 per share) | — |  |  | (4,059) |  |  | — |  |  | — |  |  | (4,059) |
Stock-based compensation expense | 1,175 |  |  | — |  |  | — |  |  | — |  |  | 1,175 |
Repurchase of employee common stock for tax withholdings | (396) |  |  | — |  |  | — |  |  | — |  |  | (396) |
Tredegar common stock purchased by trust for savings restoration plan | — |  |  | 13 |  |  | (13) |  |  | — |  |  | — |
Balance March 31, 2022 | $ | 55,953 |  |  | $ | 293,563 |  |  | $ | (2,148) |  |  | $ | (135,500) |  |  | $ | 211,868 |

The following summarizes the changes in shareholders’ equity for the three month period ended March 31, 2021:

| Common Stock |  | Retained Earnings |  | Trust for Savings Restoration Plan |  | Accumulated Other Comprehensive Income (Loss) |  | Total Shareholders’ Equity
Balance at January 1, 2021 | $ | 50,066 |  |  | $ | 239,480 |  |  | $ | (2,087) |  |  | $ | (178,404) |  |  | $ | 109,055 |
Net income (loss) | — |  |  | 9,031 |  |  | — |  |  | — |  |  | 9,031 |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | (2,648) |  |  | (2,648) |
Derivative financial instruments adjustment | — |  |  | — |  |  | — |  |  | (236) |  |  | (236) |
Amortization of prior service costs and net gains or losses | — |  |  | — |  |  | — |  |  | 3,319 |  |  | 3,319 |
Cash dividends declared ($0.12 per share) | — |  |  | (4,025) |  |  | — |  |  | — |  |  | (4,025) |
Stock-based compensation expense | 576 |  |  | — |  |  | — |  |  | — |  |  | 576 |
Shares issued upon exercise of stock options | 915 |  |  | — |  |  | — |  |  | — |  |  | 915 |
Tredegar common stock purchased by trust for savings restoration plan | — |  |  | 10 |  |  | (10) |  |  | — |  |  | — |
Balance at March 31, 2021 | $ | 51,557 |  |  | $ | 244,496 |  |  | $ | (2,097) |  |  | $ | (177,969) |  |  | $ | 115,987 |

See accompanying notes to financial statements.
6

TREDEGAR CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. BASIS OF PRESENTATION
In the opinion of management, the accompanying condensed consolidated financial statements of Tredegar Corporation and its subsidiaries (“Tredegar,” “the Company,” “we,” “us” or “our”) contain all adjustments necessary to state fairly, in all material respects, Tredegar’s condensed consolidated financial position as of March 31, 2022, the condensed consolidated results of operations for the three months ended March 31, 2022 and 2021, the condensed consolidated cash flows for the three months ended March 31, 2022 and 2021, and the condensed consolidated changes in shareholders’ equity for the three months ended March 31, 2022 and 2021, in accordance with U.S. generally accepted accounting principles (“GAAP”). All such adjustments, unless otherwise detailed in the notes to the condensed consolidated financial statements, are deemed to be of a normal, recurring nature.
The Company operates on a calendar fiscal year except for the Aluminum Extrusions segment, which operates on a 52/53-week fiscal year basis. As such, the fiscal first quarter for 2022 and 2021 for this segment references 13-week periods ended March 27, 2022 and March 28, 2021. The Company does not believe the impact of reporting the results of this segment as stated above is material to the consolidated financial results. The Company may fund or receive cash from the Aluminum Extrusions segment based on Aluminum Extrusion’s cash flows from operations during the intervening period from Aluminum Extrusion’s fiscal quarter end and the Company’s fiscal quarter end. There was no intercompany funding with Aluminum Extrusions between March 27, 2022 and March 31, 2022.
The financial position data as of December 31, 2021 that is included herein was derived from the audited consolidated financial statements provided in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”) but does not include all disclosures required by GAAP. These financial statements should be read in conjunction with the consolidated financial statements and related notes included in the 2021 Form 10-K.
The results of operations for the three months ended March 31, 2022, are not necessarily indicative of the results to be expected for the full year.
Accounting Standards Not Yet Adopted.
In March 2020, the FASB issued ASU 2020-04, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions affected by the discontinuation of the London Interbank Offered Rate or by another reference rate expected to be discontinued because of reference rate reform. The guidance was effective beginning March 12, 2020 and can be applied prospectively through December 31, 2022. In January 2021, the FASB issued ASU 2021-01, which clarified the scope and application of the original guidance. The Company is currently evaluating the potential impact of adopting this guidance, but does not expect it to have a material impact on the consolidated financial statements.
2. ACCOUNTS AND OTHER RECEIVABLES
As of March 31, 2022 and December 31, 2021, accounts receivable and other receivables, net include the following:

| March 31, |  | December 31,
(In thousands) | 2022 |  | 2021
Customer receivables | $ | 128,930 |  |  | $ | 102,090 |
Other receivables | 2,517 |  |  | 2,958 |
Total accounts and other receivables | 131,447 |  |  | 105,048 |
Less: Allowance for bad debts | (1,888) |  |  | (1,736) |
Total accounts and other receivables, net | $ | 129,559 |  |  | $ | 103,312 |

3. INVENTORIES
The components of inventories are as follows:

(In thousands) | March 31, 2022 |  | December 31, 2021
Finished goods | $ | 26,796 |  |  | $ | 25,199 |
Work-in-process | 18,122 |  |  | 11,955 |
Raw materials | 39,481 |  |  | 32,958 |
Stores, supplies and other | 20,161 |  |  | 18,457 |
Total | $ | 104,560 |  |  | $ | 88,569 |

7

4. PENSION AND OTHER POSTRETIREMENT BENEFITS
Tredegar sponsors a noncontributory defined benefit (pension) plan covering certain current and former U.S. employees. As of January 31, 2018, the plan no longer accrued benefits associated with crediting employees for service, thereby freezing all future benefits under the plan. On February 10, 2022, Tredegar announced the initiation of a process to terminate and settle its frozen defined benefit pension plan, which could take up to 24 months to complete. In connection therewith, on February 9, 2022, the Company contributed $50 million to the pension plan (the “Special Contribution”). The Company estimates that, with the Special Contribution, there will be no required minimum contributions to the pension plan until final settlement.
Tredegar also has a non-qualified supplemental pension plan covering certain employees. Effective December 31, 2005, further participation in this plan was terminated and benefit accruals for existing participants were frozen. Pension expense recognized for this plan was immaterial in the first quarter of 2022 and 2021, respectively. This information has been included in the pension benefit table below.
The components of net periodic benefit cost for the pension and other postretirement benefit programs reflected in the condensed consolidated statements of income for the three months ended March 31, 2022 and 2021, are shown below:

| Pension Benefits |  | Other Post-Retirement Benefits
| Three Months Ended March 31, |  | Three Months Ended March 31,
(In thousands) | 2022 |  | 2021 |  | 2022 |  | 2021
Service cost | $ | — |  |  | $ | — |  |  | $ | 5 |  |  | $ | 9 |
Interest cost | 2,225 |  |  | 2,102 |  |  | 51 |  |  | 50 |
Expected return on plan assets | (2,055) |  |  | (2,862) |  |  | — |  |  | — |
Amortization of prior service costs, (gains) losses and net transition asset | 3,284 |  |  | 4,265 |  |  | (34) |  |  | (24) |
Net periodic benefit cost | $ | 3,454 |  |  | $ | 3,505 |  |  | $ | 22 |  |  | $ | 35 |

Pension and other postretirement liabilities were $29.0 million and $78.9 million at March 31, 2022 and December 31, 2021, respectively ($0.7 million included in “Accrued expenses” at March 31, 2022 and December 31, 2021, respectively, with the remainder included in “Pension and other postretirement benefit obligations, net” in the condensed consolidated balance sheets).
Tredegar funds its other postretirement benefits on a claims-made basis; for 2022, the Company anticipates the amount will be consistent with amounts paid for the year ended December 31, 2021, or approximately $0.5 million.
5. OTHER INCOME (EXPENSE), NET
Other income (expense), net consists of the following:

|  |  | Three Months Ended March 31,
(In thousands) |  |  |  |  | 2022 |  | 2021
Gain on investment in kaléo(a) |  |  |  |  | $ | — |  |  | $ | 718 |
Transition service fees, net of corporate costs associated with the divested Personal Care business |  |  |  |  | (32) |  |  | 304 |
COVID-19-related expenses, net of relief (b) |  |  |  |  | (212) |  |  | (19) |
Write-down of investment in Harbinger Capital Partners Special Situations Fund(c) |  |  |  |  | (7) |  |  | (148) |
Other |  |  |  |  | (16) |  |  | (95) |
Total |  |  |  |  | $ | (267) |  |  | $ | 760 |
(a) The gain in the first three months of 2021 includes a $0.3 million dividend received from kaléo in the first quarter of 2021. See Note 12. (b) Costs associated with operating under COVID-19 conditions include employee overtime expenses associated with absenteeism, personal protective equipment supplies and facility maintenance. (c) Represents the unrealized loss on the Company’s investment in Harbinger Capital Partners Special Situations Fund L.P. that had a fair value of $0.2 million as of March 31, 2022 and $0.2 million as of December 31, 2021 reported in "Other assets" in the condensed consolidated balance sheet.

8

6. EARNINGS PER SHARE
Basic earnings per share is computed by dividing net income (loss) from continuing and discontinued operations by the weighted average number of shares of common stock outstanding. Diluted earnings per share is computed by dividing net income (loss) from continuing and discontinued operations by the weighted average common and potentially dilutive common equivalent shares outstanding, determined as follows:

|  |  | Three Months Ended
|  |  | March 31,
(In thousands) |  |  |  |  | 2022 |  | 2021
Weighted average shares outstanding used to compute basic earnings per share |  |  |  |  | 33,654 |  |  | 33,406 |
Incremental dilutive shares attributable to stock options and restricted stock |  |  |  |  | 42 |  |  | 238 |
Shares used to compute diluted earnings per share |  |  |  |  | 33,696 |  |  | 33,644 |

Incremental shares attributable to stock options and restricted stock are computed under the treasury stock method using the average market price during the related period. The average out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted stock were 2,477,708 and 411,516 for the three months ended March 31, 2022 and 2021, respectively.
7. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The changes in accumulated other comprehensive income (loss) by component are summarized as follows:

| Foreign Currency Translation |  | Gain (Loss) on Derivative Financial Instruments |  | Pension & Other Postretirement Benefit Adjust |  | Total Accumulated Other Comprehensive Income (Loss)
Balance at January 1, 2022 | (85,792) |  |  | 901 |  |  | (64,613) |  |  | (149,504) |
Other comprehensive income (loss) | 6,264 |  |  | 10,003 |  |  | — |  |  | 16,267 |
Income tax (expense) benefit | (728) |  |  | (3,190) |  |  | — |  |  | (3,918) |
Other comprehensive income (loss), net of tax | 5,536 |  |  | 6,813 |  |  | — |  |  | 12,349 |
Reclassification adjustment to net income (loss) | — |  |  | (1,157) |  |  | 3,250 |  |  | 2,093 |
Income tax (expense) benefit | — |  |  | 274 |  |  | (712) |  |  | (438) |
Reclassification adjustment to net income (loss), net of tax | — |  |  | (883) |  |  | 2,538 |  |  | 1,655 |
Other comprehensive income (loss), net of tax | 5,536 |  |  | 5,930 |  |  | 2,538 |  |  | 14,004 |
Balance at March 31, 2022 | $ | (80,256) |  |  | $ | 6,831 |  |  | $ | (62,075) |  |  | $ | (135,500) |

9

| Foreign Currency Translation |  | Gain (Loss) on Derivative Financial Instruments |  | Pension & Other Postretirement Benefit Adjust |  | Total Accumulated Other Comprehensive Income (Loss)
Balance at January 1, 2021 | (84,149) |  |  | 2,264 |  |  | (96,519) |  |  | (178,404) |
Other comprehensive income (loss) | (2,920) |  |  | 231 |  |  | — |  |  | (2,689) |
Income tax (expense) benefit | 272 |  |  | 42 |  |  | — |  |  | 314 |
Other comprehensive income (loss), net of tax | (2,648) |  |  | 273 |  |  | — |  |  | (2,375) |
Reclassification adjustment to net income (loss) | — |  |  | (655) |  |  | 4,243 |  |  | 3,588 |
Income tax (expense) benefit | — |  |  | 146 |  |  | (924) |  |  | (778) |
Reclassification adjustment to net income (loss), net of tax | — |  |  | (509) |  |  | 3,319 |  |  | 2,810 |
Other comprehensive income (loss), net of tax | (2,648) |  |  | (236) |  |  | 3,319 |  |  | 435 |
Balance at March 31, 2021 | $ | (86,797) |  |  | $ | 2,028 |  |  | $ | (93,200) |  |  | $ | (177,969) |

The amounts reclassified out of accumulated other comprehensive income (loss) related to pension and other postretirement benefits is included in the computation of net periodic pension costs, see Note 4 for additional details.
8. DERIVATIVES
Tredegar uses derivative financial instruments for the purpose of hedging margin exposure from fixed-price forward sales contracts in Aluminum Extrusions and exposure from currency volatility that exists as part of ongoing business operations in Flexible Packaging Films. These derivative financial instruments are designated as and qualify as cash flow hedges and are recognized in the condensed consolidated balance sheet at fair value. If individual derivative instruments with the same counterparty can be settled on a net basis, the Company records the corresponding derivative fair values as a net asset or net liability.
In the normal course of business, Aluminum Extrusions enters into fixed-price forward sales contracts with certain customers for the future sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge margin exposure created from the fixing of future sales prices relative to volatile raw material (aluminum) costs, Aluminum Extrusions enters into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled purchases for the firm sales commitments. The fixed-price firm sales commitments and related hedging instruments generally have durations of not more than 12 months. The notional amount of aluminum futures contracts that hedged future purchases of aluminum to meet fixed-price forward sales contract obligations was $24.2 million (14.3 million pounds of aluminum) at March 31, 2022 and $22.1 million (14.9 million pounds of aluminum) at December 31, 2021.
The table below summarizes the location and gross amounts of aluminum futures contract fair values (Level 2) in the condensed consolidated balance sheets as of March 31, 2022 and December 31, 2021:

| March 31, 2022 |  | December 31, 2021
(In thousands) | Balance Sheet Account |  | Fair Value |  | Balance Sheet Account |  | Fair Value
Derivatives Designated as Hedging Instruments |  |  |  |  |  |  |
Asset derivatives: Aluminum futures contracts | Prepaid expenses and other |  | $ | 6,665 |  |  | Prepaid expenses and other |  | $ | 2,085 |
Aluminum futures contracts | Other assets |  | 521 |  |  | Other assets |  | — |
Liability derivatives: Aluminum futures contracts | Accrued expenses |  | (43) |  |  | Accrued expenses |  | (119) |
Net asset |  |  | $ | 7,143 |  |  |  |  | $ | 1,966 |

In the event that a counterparty to an aluminum fixed-price forward sales contract chooses not to take delivery of its aluminum extrusions, the customer is contractually obligated to compensate Aluminum Extrusions for any losses on the related aluminum futures and/or forward contracts through the date of cancellation.
The Company's earnings are exposed to foreign currency exchange risk primarily through the translation of the financial statements of subsidiaries that have a functional currency other than the U.S. Dollar. The Company estimates that the net mismatch translation exposure for the Flexible Packaging Film's business unit in Brazil (“Terphane Ltda.”) of its sales and raw
10

materials quoted or priced in U.S. Dollars and its variable conversion, fixed conversion and sales, general and administrative costs (before depreciation and amortization) quoted or priced in Brazilian Real ("R$") is annual net costs of R$150 million for the full year of 2022.
Terphane Ltda. has the following outstanding foreign exchange average forward rate contracts to purchase Brazilian Real and sell U.S. Dollars:

USD Notional Amount (000s) | Average Forward Rate Contracted on USD/BRL | R$ Equivalent Amount (000s) | Applicable Month | Estimated % of Terphane Ltda. R$ Operating Cost Exposure Hedged
$1,615 | 5.4247 | R$8,761 | Apr-22 | 68%
$1,647 | 5.4545 | R$8,984 | May-22 | 70%
$1,596 | 5.4890 | R$8,760 | Jun-22 | 68%
$1,719 | 5.5200 | R$9,489 | Jul-22 | 74%
$1,708 | 5.5560 | R$9,490 | Aug-22 | 74%
$1,780 | 5.5915 | R$9,953 | Sep-22 | 77%
$1,793 | 5.6264 | R$10,088 | Oct-22 | 78%
$1,784 | 5.6597 | R$10,097 | Nov-22 | 78%
$1,659 | 5.6962 | R$9,450 | Dec-22 | 73%
$625 | 5.5145 | R$3,447 | Jan-23 | 24%
$625 | 5.5581 | R$3,474 | Feb-23 | 24%
$625 | 5.6014 | R$3,501 | Mar-23 | 24%
$625 | 5.6446 | R$3,528 | Apr-23 | 24%
$625 | 5.6866 | R$3,554 | May-23 | 24%
$625 | 5.7323 | R$3,583 | Jun-23 | 24%
$625 | 5.7756 | R$3,610 | Jul-23 | 25%
$625 | 5.8197 | R$3,637 | Aug-23 | 25%
$625 | 5.8627 | R$3,664 | Sep-23 | 25%
$625 | 5.9028 | R$3,689 | Oct-23 | 25%
$625 | 5.9414 | R$3,713 | Nov-23 | 25%
$625 | 5.9800 | R$3,738 | Dec-23 | 25%
$22,801 | 5.6230 | R$128,210 |  | 39%

These foreign currency exchange contracts have been designated and qualify as cash flow hedges of Terphane Ltda.’s forecasted sales to customers quoted or priced in U.S. Dollars over that period. By changing the currency risk associated with these U.S. Dollar sales, the derivatives have the effect of offsetting operating costs quoted or priced in Brazilian Real and decreasing the net exposure to Brazilian Real in the condensed consolidated statements of income.
The table below summarizes the location and gross amounts of foreign currency forward contract fair values (Level 2) in the condensed consolidated balance sheets as of March 31, 2022 and December 31, 2021:

| March 31, 2022 |  | December 31, 2021
(In thousands) | Balance Sheet Account |  | Fair Value |  | Balance Sheet Account |  |  | Fair Value
Derivatives Designated as Hedging Instruments |  |  |  |  |  |  |  |
Asset derivatives: Foreign currency forward contracts | Prepaid expenses and other |  | $ | 2,127 |  |  | Prepaid expenses and other |  |  | $ | — |
Foreign currency forward contracts | Other assets |  | 481 |  |  | Other assets |  |  | — |
Liability derivatives: Foreign currency forward contracts | Accrued expenses |  | — |  |  | Accrued expenses |  |  | (1,255) |
Net asset (liability) |  |  | $ | 2,608 |  |  |  |  |  | $ | (1,255) |

11

These derivative contracts involve elements of market risk that are not reflected on the condensed consolidated balance sheet, including the risk of dealing with counterparties and their ability to meet the terms of the contracts. The counterparties to any forward purchase commitments are major aluminum brokers and suppliers, and the counterparties to any aluminum futures contracts are major financial institutions. Fixed-price forward sales contracts are only made available to the best and most credit-worthy customers. The counterparties to the Company’s foreign currency cash flow hedge contracts are major financial institutions.
The pre-tax effect on net income (loss) and other comprehensive income (loss) of derivative instruments classified as cash flow hedges and described in the previous paragraphs for the three month periods ended March 31, 2022 and 2021 is summarized in the table below:

| Cash Flow Derivative Hedges
| Three Months Ended March 31,
| Aluminum Futures Contracts |  | Foreign Currency Forwards
| 2022 |  | 2021 |  | 2022 |  | 2021
Amount of pre-tax gain (loss) recognized in other comprehensive income (loss) | $ | 6,182 |  |  | $ | 1,515 |  |  | $ | — |  | $ | 3,821 |  |  | $ | — |  |  | $ | (1,283) |
Location of gain (loss) reclassified from accumulated other comprehensive income (loss) into net income (effective portion) | Cost of goods sold |  | Cost of goods sold |  | Cost of goods sold | Selling, general & admin |  | Cost of goods sold |  | Selling, general & admin
Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income (loss) to net income (effective portion) | $ | (1,005) |  |  | $ | 640 |  |  | $ | (15) |  | $ | (137) |  |  | $ | 17 |  |  | $ | (2) |

As of March 31, 2022, the Company expects $3.5 million of unrealized after-tax gains on aluminum and foreign currency derivative instruments reported in accumulated other comprehensive income (loss) to be reclassified to earnings within the next 12 months. For the three month periods ended March 31, 2022 and 2021, net gains or losses realized, from previously unrealized net gains or losses on hedges that had been discontinued, were not material.
9. INCOME TAXES
Tredegar recorded tax expense of $0.8 million on pre-tax income from continuing operations of $17.2 million in the first three months of 2022. Therefore, the effective tax rate in the first three months of 2022 was 4.5%, compared to 24.4% in the first three months of 2021. The decrease in the effective tax rate for continuing operations is primarily due to a discrete benefit recorded in the first quarter of 2022 resulting from the implementation of new U.S. tax regulations associated with foreign tax credits published by the U.S. Treasury and Internal Revenue Service on January 4, 2022. These regulations overhaul various components of the foreign tax credit regime including the determination of creditable foreign taxes and limit the amount of foreign taxes that are creditable against U.S. income taxes. As the result of these regulations, future Brazilian income tax will be deductible, but not creditable, in the U.S. The accounting rules require a reduction of the U.S. deferred tax liability previously established related to anticipated future income from Brazil. The tax effect of the reduction of the U.S. deferred tax liability resulted in the discrete tax benefit described above. This one-time discrete benefit is expected to reduce the effective tax rate for the remainder of 2022, which will be offset by an expected increase to the effective tax rate as the result of Brazilian income tax no longer being creditable in the U.S. for the foreseeable future. Total deferred tax assets declined during the first quarter of 2022 compared to December 31, 2021 primarily due to changes in other comprehensive income and the projected utilization of foreign tax credits partially offset by the change in the deferred tax liability discussed above.
Tredegar accrues U.S. federal income taxes on unremitted earnings of foreign subsidiaries where required. However, due to changes in the taxation of dividends under the U.S. Tax Cuts and Jobs Act of 2017, Tredegar will only record U.S. federal income taxes on unremitted earnings of its foreign subsidiaries where Tredegar cannot take steps to eliminate any potential tax on future distributions from its foreign subsidiaries.
The Brazilian federal statutory income tax rate is a composite of 34.0% (25.0% of income tax and 9.0% of social contribution on income). Terphane Ltda.’s manufacturing facility in Brazil is the beneficiary of certain income tax incentives that allow for a reduction in the statutory Brazilian federal income tax rate to 15.25% levied on the operating profit on certain of its products. The incentives have been granted for a 13-year period, from the commencement date of January 1, 2015. The benefit from the tax incentives was $1.5 million in the first three months of 2022 and 2021.
Tredegar and its subsidiaries file income tax returns in the U.S., various states, and jurisdictions outside the U.S. With exceptions for some U.S. states and non-U.S. jurisdictions, Tredegar and its subsidiaries are no longer subject to U.S. federal, state or non-U.S. income tax examinations by tax authorities for years before 2018.
12

10. BUSINESS SEGMENTS
The Company’s business segments are Aluminum Extrusions, PE Films, and Flexible Packaging Films. Information by business segment is reported below. There are no accounting transactions between segments and no allocations to segments.
The Company’s reportable segments are based on its method of internal reporting, which is generally segregated by differences in products. Accounting standards for presentation of segments require an approach based on the way the Company organizes the segments for making operating decisions and how the chief operating decision maker (“CODM”) assesses performance. EBITDA from ongoing operations is the key profitability measure used by the CODM (Tredegar’s President and Chief Executive Officer) for purposes of assessing financial performance. The Company uses sales less freight (“net sales”) from continuing operations as its measure of revenues from external customers at the segment level. This measure is separately included in the financial information regularly provided to the CODM.
13

The following table presents net sales and EBITDA from ongoing operations by segment for the three months ended March 31, 2022 and 2021:

|  |  | Three Months Ended March 31,
(In thousands) |  |  |  |  | 2022 |  | 2021
Net Sales |  |  |  |  |  |  |
Aluminum Extrusions |  |  |  |  | $ | 158,110 |  |  | $ | 118,125 |
PE Films |  |  |  |  | 31,131 |  |  | 27,953 |
Flexible Packaging Films |  |  |  |  | 39,244 |  |  | 32,521 |
Total net sales |  |  |  |  | 228,485 |  |  | 178,599 |
Add back freight |  |  |  |  | 8,081 |  |  | 6,223 |
Sales as shown in the condensed consolidated statements of income |  |  |  |  | $ | 236,566 |  |  | $ | 184,822 |
EBITDA from Ongoing Operations |  |  |  |  |  |  |
Aluminum Extrusions: |  |  |  |  |  |  |
Ongoing operations: |  |  |  |  |  |  |
EBITDA |  |  |  |  | $ | 23,919 |  |  | $ | 13,302 |
Depreciation & amortization |  |  |  |  | (4,261) |  |  | (4,130) |
EBIT |  |  |  |  | 19,658 |  |  | 9,172 |
Plant shutdowns, asset impairments, restructurings and other |  |  |  |  | (105) |  |  | 183 |
PE Films: |  |  |  |  |  |  |
Ongoing operations: |  |  |  |  |  |  |
EBITDA |  |  |  |  | 7,047 |  |  | 7,213 |
Depreciation & amortization |  |  |  |  | (1,595) |  |  | (1,420) |
EBIT |  |  |  |  | 5,452 |  |  | 5,793 |
Plant shutdowns, asset impairments, restructurings and other |  |  |  |  | (102) |  |  | (124) |
Flexible Packaging Films: |  |  |  |  |  |  |
Ongoing operations: |  |  |  |  |  |  |
EBITDA |  |  |  |  | 5,035 |  |  | 9,623 |
Depreciation & amortization |  |  |  |  | (550) |  |  | (466) |
EBIT |  |  |  |  | 4,485 |  |  | 9,157 |
Plant shutdowns, asset impairments, restructurings and other |  |  |  |  | (43) |  |  | (38) |
Total |  |  |  |  | 29,345 |  |  | 24,143 |
Interest income |  |  |  |  | 29 |  |  | 7 |
Interest expense |  |  |  |  | 786 |  |  | 822 |
Gain on investment in kaléo |  |  |  |  | — |  |  | 718 |
Stock option-based compensation costs |  |  |  |  | 631 |  |  | 468 |
Corporate expenses, net |  |  |  |  | 10,722 |  |  | 10,863 |
Income (loss) from continuing operations before income taxes |  |  |  |  | 17,235 |  |  | 12,715 |
Income tax expense (benefit) |  |  |  |  | 778 |  |  | 3,097 |
Income (loss) from continuing operations |  |  |  |  | 16,457 |  |  | 9,618 |
Income (loss) from discontinued operations, net of tax |  |  |  |  | (35) |  |  | (587) |
Net income (loss) |  |  |  |  | $ | 16,422 |  |  | $ | 9,031 |

14

The following table presents identifiable assets by segment at March 31, 2022 and December 31, 2021:

(In thousands) | March 31, 2022 |  | December 31, 2021
Aluminum Extrusions | $ | 311,971 |  |  | $ | 280,521 |
PE Films | 115,307 |  |  | 113,613 |
Flexible Packaging Films | 92,852 |  |  | 75,269 |
Subtotal | 520,130 |  |  | 469,403 |
General corporate | 18,742 |  |  | 23,482 |
Cash and cash equivalents | 25,648 |  |  | 30,521 |
Discontinued operations | 151 |  |  | 178 |
Total | $ | 564,671 |  |  | $ | 523,584 |

The following tables disaggregate the Company’s revenue by geographic area and product group for the three months ended March 31, 2022 and 2021:

Net Sales by Geographic Area (a)
|  |  | Three Months Ended March 31,
(In thousands) |  |  |  |  | 2022 |  | 2021
United States |  |  |  |  | $ | 182,138 |  |  | $ | 132,897 |
Exports from the United States to: |  |  |  |  |  |  |
Asia |  |  |  |  | 12,465 |  |  | 13,362 |
Latin America |  |  |  |  | 1,441 |  |  | 1,102 |
Canada |  |  |  |  | 4,193 |  |  | 5,434 |
Europe |  |  |  |  | 1,363 |  |  | 955 |
Operations outside the United States: |  |  |  |  |  |  |
Brazil |  |  |  |  | 26,885 |  |  | 24,849 |
Total |  |  |  |  | $ | 228,485 |  |  | $ | 178,599 |
(a) Export sales relate entirely to PE Films. Operations in Brazil relate entirely to Flexible Packaging Films.

The Company’s facilities in Pottsville, PA (“PV”) and Guangzhou, China (“GZ”) have a tolling arrangement whereby certain surface protection films are manufactured in GZ for a fee with raw materials supplied from PV that are then shipped by GZ directly to customers principally in the Asian market, but paid by customers directly to PV. Amounts associated with this intercompany tolling arrangement are reported in the table above as export sales from the U.S. to Asia, and include net sales of $6.5 million and $6.9 million in the first three months of 2022 and 2021, respectively.
15

Net Sales by Product Group
|  |  | Three Months Ended March 31,
(In thousands) |  |  |  |  | 2022 |  | 2021
Aluminum Extrusions: |  |  |  |  |  |  |
Nonresidential building & construction |  |  |  |  | $ | 80,921 |  |  | $ | 57,229 |
Consumer durables |  |  |  |  | 16,891 |  |  | 13,152 |
Automotive |  |  |  |  | 13,841 |  |  | 11,415 |
Residential building & construction |  |  |  |  | 16,465 |  |  | 12,708 |
Electrical |  |  |  |  | 7,287 |  |  | 7,180 |
Machinery & equipment |  |  |  |  | 12,945 |  |  | 8,925 |
Distribution |  |  |  |  | 9,760 |  |  | 7,516 |
Subtotal |  |  |  |  | 158,110 |  |  | 118,125 |
PE Films: |  |  |  |  |  |  |
Surface protection films |  |  |  |  | 22,148 |  |  | 20,601 |
Packaging |  |  |  |  | 8,983 |  |  | 7,352 |
Subtotal |  |  |  |  | 31,131 |  |  | 27,953 |
Flexible Packaging Films |  |  |  |  | 39,244 |  |  | 32,521 |
Total |  |  |  |  | $ | 228,485 |  |  | $ | 178,599 |

11. DIVESTITURES
Personal Care Films
In 2020, the Company completed the sale of Personal Care Films for an aggregate purchase price of $60.5 million, subject to customary adjustments. The Company agreed to provide certain transition services related to finance, human resources and information technology ("IT") that ended during the second quarter of 2021, resulting in final cash proceeds of $64.1 million. Personal Care Films was previously reported in the PE Films segment.
The following table summarizes the financial results of discontinued operations reflected in the condensed consolidated statements of income for the three and three months ended March 31, 2022 and 2021:

|  |  | Three Months Ended March 31,
(In thousands) |  |  |  |  | 2022 |  | 2021
Costs and expenses: |  |  |  |  |  |  |
Selling, general and administrative |  |  |  |  | 45 |  |  | 1,050 |
Adjustment to the fair value estimates used in the disposal of Personal Care Films(a) |  |  |  |  | — |  |  | (299) |
Total |  |  |  |  | 45 |  |  | 751 |
Income (loss) from discontinued operations before income taxes |  |  |  |  | (45) |  |  | (751) |
Income tax expense (benefit) |  |  |  |  | (10) |  |  | (164) |
Income (loss) from discontinued operations, net of tax |  |  |  |  | $ | (35) |  |  | $ | (587) |
(a) Represents a net increase to the estimated fair value of Personal Care Films primarily due to lower costs associated with IT transition-related services to provide the seller developed assets, which did not exist at the time of the sale, to support the seller's IT infrastructure.

16

The assets and liabilities of the discontinued operations reflected in the condensed consolidated balance sheets as of March 31, 2022 and December 31, 2021, respectively, were as follows:

| March 31, |  | December 31,
(In thousands) | 2022 |  | 2021
Assets |  |  |
Prepaid expenses and other (a) | $ | 151 |  |  | $ | 178 |
Liabilities |  |  |
Accrued expenses (a) | $ | 178 |  |  | $ | 193 |
(a) The condensed consolidated balance sheet of discontinued operations as of March 31, 2022 includes $0.2 million of other receivables related to the settlement of customary post-closing adjustments and other miscellaneous accrued expenses of $0.2 million. The condensed consolidated balance sheet of discontinued operations as of December 31, 2021 includes $0.2 million of other receivables related to the settlement of customary post-closing adjustments and other miscellaneous accrued expenses of $0.2 million.

The following table provides significant operating and investing cash flow information for discontinued operations:

| Three Months Ended March 31,
(In thousands) | 2022 |  | 2021
Operating activities |  |  |
Other | — |  |  | (299) |

12. INVESTMENTS
In August 2007 and December 2008, the Company made an aggregate investment of $7.5 million in kaleo, Inc. (“kaléo”), a privately held specialty pharmaceutical company dedicated to building innovative solutions for serious and life-threatening medical conditions. Tredegar historically accounted for its investment in kaléo under the fair value option. At the time of the initial investment, the Company elected the fair value option of accounting since its investment objectives were similar to those of venture capitalists, which typically do not have controlling financial interests. kaléo’s stock is not publicly traded.
On December 27, 2021, the Company completed the sale of its investment interests in kaléo (Series A-3 Preferred Stock, Series B Preferred Stock and common stock) that, taken together, represented on a fully-diluted basis an approximate 18% interest in kaléo. Tredegar received closing cash proceeds of $47.1 million. A pre-tax gain of $0.7 million on the Company’s investment in kaléo was recognized in the first quarter ended March 31, 2021 which is reported in “Other income (expense), net” in the condensed consolidated statements of income. The gain in 2021 includes a $0.3 million dividend received from kaléo in the first quarter of 2021.
17

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Forward-looking and Cautionary Statements
Some of the information contained in this Quarterly Report on Form 10-Q ("Form 10-Q") press release may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When the Company uses the words “believe,” “estimate,” “anticipate,” “appear to,” “expect,” “project,” “plan,” “likely,” “may” and similar expressions, it does so to identify forward-looking statements. Such statements are based on the Company's then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. In addition, the Company's current projections for its businesses could be materially affected by the highly uncertain impact of the COVID-19 pandemic. As a consequence, the Company's results could differ significantly from its projections, depending on, among other things, the ultimate impact of the pandemic on employees, supply chains, customers and the U.S. and world economies. Accordingly, you should not place undue reliance on these forward-looking statements. Factors that could cause actual results to differ from expectations include, without limitation, the following:
•loss or gain of sales to significant customers on which the Company’s business is highly dependent;
•inability to achieve sales to new customers to replace lost business;
•inability to develop, efficiently manufacture and deliver new products at competitive prices;
•failure of the Company’s customers to achieve success or maintain market share;
•failure to protect our intellectual property rights;
•risks of doing business in countries outside the U.S. that affect our international operations;
•political, economic, and regulatory factors concerning the Company’s products;
•uncertain economic conditions in countries in which the Company does business, including rising inflation and the effects of the Russian invasion of Ukraine;
•competition from other manufacturers, including manufacturers in lower-cost countries and manufacturers benefiting from government subsidies;
•impact of fluctuations in foreign exchange rates;
•movement of pension plan assets and liabilities up through initiating hedging activities to fix underfunding amounts and assumptions thereafter relating to differences between the ultimate settlement benefit obligation and the projected benefit obligation, census data, administrative costs, the effectiveness of hedging activities and discounts required to liquidate non-public securities held by the plan;
•an increase in the operating costs incurred by the Company’s business units, including, for example, the cost of raw materials and energy;
•inability to successfully identify, complete or integrate strategic acquisitions; failure to realize the expected benefits of such acquisitions and assumption of unanticipated risks in such acquisitions;
•disruptions to the Company’s manufacturing facilities, including those resulting from labor shortages;
•the impact of public health epidemics on employees, production and the global economy, such as the COVID-19 pandemic;
•an information technology system failure or breach;
•the impact of the imposition of tariffs and sanctions on imported aluminum ingot used by Bonnell Aluminum;
•the impact of new tariffs, duties or other trade restrictions imposed as a result of trade tensions between the U.S. and other countries;
•the termination of anti-dumping duties on products imported to Brazil that compete with products produced by Flexible Packaging;
•failure to establish and maintain effective internal control over financial reporting;
and the other factors discussed in the reports Tredegar files with or furnishes to the Securities and Exchange Commission (the “SEC”) from time to time, including the risks and important factors set forth in additional detail in Part I, Item 1A of Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2021 (the “2021 Form 10-K”). Readers are urged to review and consider carefully the disclosures Tredegar makes in its filings with the SEC.
18

Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.
References herein to “Tredegar,” “the Company,” “we,” “us” and “our” are to Tredegar Corporation and its subsidiaries, collectively, unless the context otherwise indicates or requires.
Unless otherwise stated or indicated, all comparisons are to the prior year period. References to "Notes" are to notes to our condensed consolidated financial statements found in Part I, Item 1 of this Form 10-Q.
Critical Accounting Policies and Estimates
In the ordinary course of business, the Company makes a number of estimates and assumptions relating to the reporting of results of operations and financial position in the preparation of financial statements in conformity with GAAP. The Company believes the estimates, assumptions and judgments described in the section “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates” in the 2021 Form 10-K have the greatest potential impact on our financial statements, so Tredegar considers these to be its critical accounting policies. Since December 31, 2021, there have been no changes in these policies that have had a material impact on our results of operations or financial position.
Business Overview
Tredegar Corporation is an industrial manufacturer with three primary businesses: custom aluminum extrusions for the North American building and construction ("B&C"), automotive and specialty end-use markets through its Aluminum Extrusions segment; surface protection films for high-technology applications in the global electronics industry through its PE Films segment; and specialized polyester films primarily for the Latin American flexible packaging market through its Flexible Packaging Films segment. With approximately 2,400 employees, the Company operates manufacturing facilities in North America, South America, and Asia.
Earnings before interest, taxes, depreciation and amortization (“EBITDA”) from ongoing operations is the measure of segment profit and loss used by Tredegar’s chief operating decision maker ("CODM") for purposes of assessing financial performance. The Company uses sales less freight (“net sales”) from continuing operations as its measure of revenues from external customers at the segment level. This measure is separately included in the financial information regularly provided to the CODM.
Earnings before interest and taxes ("EBIT") from ongoing operations is a non-GAAP financial measure included in the reconciliation of segment financial information to consolidated results for the Company. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under generally accepted accounting standards in the United States ("GAAP") and should not be considered as an alternative to net income as defined by GAAP. We believe that EBIT is a widely understood and utilized metric that is meaningful to certain investors and that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations.
First Quarter Financial Results Highlights
First quarter 2022 net income from continuing operations was $16.5 million ($0.49 per diluted share) compared with net income from continuing operations of $9.6 million ($0.29 per diluted share) in the first quarter of 2021.
•EBITDA from ongoing operations for Aluminum Extrusions of $23.9 million was $10.6 million higher than the first quarter of 2021
•EBITDA from ongoing operations for PE Films of $7.0 million was $0.2 million lower than the first quarter of 2021
•EBITDA from ongoing operations for Flexible Packaging Films of $5.0 million was $4.6 million lower than the first quarter of 2021
All three of the Company's business segments continue to manage through supply chain disruptions and inflationary cost pressures, including raw material cost increases, shortages, transportation cost increases and delays. Refer to Quantitative and Qualitative Disclosures About Market Risk below for additional information on raw material price trends. The Company attempts to mitigate the effects of increased costs through price increases and contractual pass-through provisions. At Bonnell Aluminum, labor shortages associated with the COVID-19 operating environment have resulted in production challenges and inefficiencies. However, current bookings and backlog remain at record high levels.
Other losses related to asset impairments and costs associated with exit and disposal activities for continuing operations were not material for the three months ended March 31, 2022 and 2021, respectively. Gains and losses associated with plant shutdowns, asset impairments, restructurings and other items are described in Results of Operations below.
19

Results of Operations
First Quarter of 2022 Compared with the First Quarter of 2021
The following table presents a bridge of consolidated net income (loss) from continuing operations from first quarter of 2021 to first quarter of 2022 with related management's discussion and analysis below the table.

(In thousands) |  |
Net income from continuing operations for the three months ended March 31, 2021 |  | $ | 9,618 |
Income tax expense (benefit) |  | 3,097 |
Income (loss) from continuing operations before income taxes |  | 12,715 |
Increase (decrease) in income from increases (decreases) in the following items: |  |
Sales |  | 51,744 |
Other income (expense), net |  | (1,027) |
Total |  | 50,717 |
Increase (decrease) in income from (increases) decreases in the following items: |  |
Cost of goods sold |  | (41,975) |
Freight |  | (1,858) |
Selling, general and administrative |  | (2,898) |
Other |  | 534 |
Total |  | (46,197) |
Income (loss) from continuing operations before income taxes |  | 17,235 |
Income tax expense (benefit) |  | 778 |
Net income from continuing operations for the three months ended March 31, 2022 |  | $ | 16,457 |

Sales in the first quarter of 2022 increased by $51.7 million compared with the first quarter of 2021. Net sales (sales less freight) in Aluminum Extrusions increased $40.0 million, primarily due to an increase in average selling prices to cover significantly higher aluminum raw material costs and higher operating costs, partially offset by lower sales volume. Net sales increased $3.2 million in PE Films, primarily due to higher volume in Surface Protection and higher selling prices for overwrap films. Net sales in Flexible Packaging Films increased $6.7 million, primarily due to higher selling prices from the pass-through of higher resin costs and favorable product mix, partially offset by lower sales volume. For more information on net sales and volume, see the Segment Operations Review below.
Other income decreased $1.0 million in the first quarter of 2022 compared to the first quarter of 2021, primarily due to a 2021 gain on the Company's investment in kaléo inc., which was historically accounted for under the fair value option and sold in the fourth quarter of 2021, and the non-recurring 2021 transition service fee income, net of corporate costs associated with the divested Personal Care Films business. See Note 5 for additional information.
Consolidated gross profit (sales minus cost of goods sold and freight) as a percentage of sales (gross profit margin) was 19.1% in the first quarter of 2022 compared to 20.2% in the first quarter of 2021. The gross profit margin in Aluminum Extrusions increased primarily due to an increase in average selling prices to cover significantly higher aluminum raw material costs and higher operating costs. The gross profit margin in PE Films decreased primarily due to lower Surface Protection sales related to previously disclosed customer product transitions, pricing pressures for products unrelated to the customer product transitions, higher freight expense, partially offset by higher volume, favorable mix and the pass-through lag associated with resin costs. The gross profit margin in Flexible Packaging Films decreased primarily due to higher raw material costs, higher variable costs and lower sales volume, partially offset by higher selling prices from the pass-through of higher resin costs, favorable absorption of fixed costs and favorable product mix.
As a percentage of sales, selling, general and administrative (“SG&A”) and research and development ("R&D") expenses were 9.6% in the first quarter of 2022, compared with 10.9% in the first quarter of 2021. SG&A expenses and net sales increased year-over-year, while R&D expenses remained consistent with prior year. Increased SG&A spending is primarily due to higher employee-related compensation, higher professional fees associated with business development activities, higher professional fees associated with internal controls over financial reporting, net unfavorable foreign currency translation of Real-denominated operating costs, partially offset by lower stock-based compensation.
20

The effective tax rate used to compute income taxes for continuing operations in the first three months of 2022 was 4.5%, compared to 24.4% in the first three months of 2021. The decrease in the effective tax rate for continuing operations is primarily due to a discrete benefit recorded in the first quarter of 2022 resulting from the implementation of new U.S. tax regulations associated with foreign tax credits published by the U.S. Treasury and Internal Revenue Service on January 4, 2022. These regulations overhaul various components of the foreign tax credit regime including the determination of creditable foreign taxes and limit the amount of foreign taxes that are creditable against U.S. income taxes. This one-time discrete benefit is expected to reduce the effective tax rate for the remainder of 2022, which will be offset by an expected increase to the effective tax rate as the result of Brazilian income tax no longer being creditable in the U.S. for the foreseeable future. See Note 9 for additional information.
Pre-tax gains and losses associated with plant shutdowns, asset impairments, restructurings and other items for continuing operations in the first quarters of 2022 and 2021 detailed below are shown in the statements of net sales and EBITDA from ongoing operations by segment table in Note 10 and are included in “Asset impairments and costs associated with exit and disposal activities, net of adjustments” in the condensed consolidated statements of income, unless otherwise noted.

| Three Months Ended March 31,
($ in millions) | 2022 | 2021
Aluminum Extrusions: |  |
(Gains) losses from sale of assets, investment writedowns and other items: |  |
COVID-19-related expenses, net of relief 2 | 0.1 |  | (0.2) |
Total for Aluminum Extrusions | $ | 0.1 |  | $ | (0.2) |
PE Films: |  |
(Gains) losses from sale of assets, investment writedowns and other items: |  |
COVID-19-related expenses 2 | $ | 0.1 |  | $ | 0.2 |
Total for PE Films | $ | 0.1 |  | $ | 0.2 |
Corporate: |  |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |  |
(Gain), net of costs associated with the sale of the Lake Zurich manufacturing facility assets | $ | — |  | 0.2 |
(Gains) losses from sale of assets, investment writedowns and other items: |  |
Professional fees associated with business development activities and other 1 | 1.5 |  | 0.8 |
Professional fees associated with internal control over financial reporting 1 | 0.4 |  | 0.2 |
Write-down of investment in Harbinger Capital Partners Special Situations Fund 2 | — |  | 0.1 |
Stock compensation expense associated with the fair value remeasurement of awards granted at the time of the 2020 special dividend 1 | — |  | 0.4 |
Transition service fees, net of corporate costs associated with the divested Personal Care Films business 2 | — |  | (0.3) |
Net periodic benefit cost for the frozen defined benefit pension plan in process of termination 4 | 3.4 |  | — |
Total for Corporate | $ | 5.3 |  | $ | 1.4 |
1. Included in “Selling, general and administrative expenses” in the condensed consolidated statements of income. 2. Included in “Other income (expense), net” in the condensed consolidated statements of income. 3. Included in “Cost of goods sold” in the condensed consolidated statements of income. 4. Prior to the $50 million contribution made to the pension plan ("Special Contribution") (see “Corporate Expenses, Interest, & Other” section of this report), GAAP pension expense was a reasonable proxy for the Company’s required minimum cash contribution to the pension plan. The Company estimates that, with the Special Contribution, there will be no required minimum cash contributions until final settlement. Pension expense under GAAP is projected to be approximately $14 million in 2022, which is mainly comprised of non-cash amortization of deferred net actuarial losses reflected in the Company’s shareholders’ equity as accumulated other comprehensive losses. Beginning in 2022, and consistent with no expected required minimum cash contributions, no pension expense is included in calculating earnings before interest, taxes, depreciation and amortization as defined in the Company’s revolving credit agreement, which is used to compute certain borrowing ratios. See Note 4 for additional information.

21

Average debt outstanding and interest rates were as follows:

| Three Months Ended March 31,
(In millions) | 2022 |  | 2021
Floating-rate debt with interest charged on a rollover basis at one-month LIBOR plus a credit spread: |  |  |
Average outstanding debt balance | $ | 103.4 |  |  | $ | 138.1 |
Average interest rate | 1.9 | % |  | 1.7 | %

Segment Operations Review
Aluminum Extrusions
A summary of results for Aluminum Extrusions is provided below:

|  |  |  |  | Three Months Ended |  | Favorable/ (Unfavorable) % Change
(In thousands, except percentages) |  |  | March 31, |
|  |  |  | 2022 |  | 2021 |
Sales volume (lbs) |  |  |  |  |  |  | 43,010 |  |  | 44,365 |  |  | (3.1)%
Net sales |  |  |  |  |  |  | $ | 158,110 |  |  | $ | 118,125 |  |  | 33.8%
Ongoing operations: |  |  |  |  |  |  |  |  |  |  |
EBITDA |  |  |  |  |  |  | $ | 23,919 |  |  | $ | 13,302 |  |  | 79.8%
Depreciation & amortization |  |  |  |  |  |  | (4,261) |  |  | (4,130) |  |  | (3.2)%
EBIT* |  |  |  |  |  |  | $ | 19,658 |  |  | $ | 9,172 |  |  | 114.3%
Capital expenditures |  |  |  |  |  |  | $ | 2,881 |  |  | $ | 2,447 |  |  |
*See the table in Note 10, "Business Segments," of this Form 10-Q ("Note 10") for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP.

First Quarter 2022 Results vs. First Quarter 2021 Results
Net sales (sales less freight) in the first quarter of 2022 increased by 33.8% versus 2021 primarily due to an increase in average selling prices to cover significantly higher aluminum raw material costs and higher operating costs, partially offset by lower sales volume. Sales volume in the first quarter of 2022 decreased by 3.1% versus 2021. Sales volume in the specialty market, which represented 34% of total volume in 2021, decreased 5.2% in the first quarter of 2022 versus 2021. Sales volume in the automotive market, which represented 8% of total volume in 2021, declined 20.0% versus the first quarter of 2021. Non-residential B&C sales volume, which represented 51% o f 2021 volume, increased 1.3% in the first quarter of 2022 versus 2021. Strong market demand in this sector has not been fully reflected in Bonnell Aluminum's first quarter 2022 results, due to pandemic-related labor shortages and resulting production inefficiencies. While the average number of direct labor employees at Bonnell Aluminum facilities increased approximately 5% and 3% in the first quarter of 2022 compared to the first and fourth quarters of 2021, respectively, the estimated average labor shortage levels was 143, 133 and 147 workers in the first quarter of 2022 and first and fourth quarters of 2021, respectively. Moreover, onboarding new employees has resulted in higher hiring and training costs in 2022 versus last year. However, current bookings and backlog remain at record high levels.
EBITDA from ongoing operations in the first quarter of 2022 increased by $10.6 million in comparison to the first quarter of 2021 primarily due to:
•Higher pricing ($14.7 million, net of the pass-through of aluminum raw material costs), partially offset by: lower volume ($0.4 million); higher labor and employee-related costs ($1.3 million) and lower labor productivity ($1.1 million); higher maintenance costs ($1.1 million); higher supply expense, including significant price increases in paint, chemicals, packaging and other supplies ($3.8 million); higher freight rates ($1.1 million); and increased selling, general and administrative expenses ($1.5 million); and
•The timing of the flow through under the first-in first-out method of aluminum raw material costs passed through to customers, previously acquired at lower prices in a quickly rising commodity pricing environment, resulted in a benefit of $7.1 million in the first quarter of 2022 versus a benefit of $1.0 million in the first quarter of 2021. The benefit in the first quarter of 2022 was net of an adverse impact from the lag in pricing ($1.8 million), in which products promised to customers at a specified price were shipped in a later period.
Aluminum Extrusions believes that it has adequate supply agreements for aluminum raw materials in 2022 and is in the process of securing supply sources to meet expected needs in 2023. R efer to Item 3. Q uantitative and Qualitative Disclosures About Market Risk in this Form 10-Q f or additional information on aluminum prices.
22

Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for Bonnell Aluminum are projected to be $31 million in 2022, including $15 million for new enterprise resource planning and manufacturing execution systems ("ERP/MES"), $6 million for infrastructure upgrades at the facilities located in Niles, Michigan, Carthage, Tennessee and Newnan, Georgia and $3 million for other strategic projects. The ERP/MES project is expected to cost $28 million over a two-year time span. In addition to strategic projects, approximately $7 million will be required to support continuity of current operations. Depreciation expense is projected to be $14 million in 2022. Amortization expense is projected to be $2 million in 2022.
PE Films
A summary of results for PE Films is provided below:

|  |  |  |  | Three Months Ended |  | Favorable/ (Unfavorable) % Change
(In thousands, except percentages) |  |  | March 31, |
|  |  |  | 2022 |  | 2021 |
Sales volume (lbs) |  |  |  |  |  |  | 10,553 |  |  | 10,244 |  |  | 3.0%
Net sales |  |  |  |  |  |  | $ | 31,131 |  |  | $ | 27,953 |  |  | 11.4%
Ongoing operations: |  |  |  |  |  |  |  |  |  |  |
EBITDA |  |  |  |  |  |  | $ | 7,047 |  |  | $ | 7,213 |  |  | (2.3)%
Depreciation & amortization |  |  |  |  |  |  | (1,595) |  |  | (1,420) |  |  | (12.3)%
EBIT* |  |  |  |  |  |  | $ | 5,452 |  |  | $ | 5,793 |  |  | (5.9)%
Capital expenditures |  |  |  |  |  |  | $ | 581 |  |  | $ | 1,233 |  |  |
* See the table in Note 10 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP.

First Quarter 2022 Results vs. First Quarter 2021 Results
Net sales increased by $3.2 million in the first quarter of 2022 versus the first quarter of 2021 primarily due to higher volume in Surface Protection and higher selling prices for overwrap films. Sales volume in Surface Protection increased 5% versus the first quarter of 2021.
EBITDA from ongoing operations in the first quarter of 2022 decreased by $0.2 million versus the first quarter of 2021, primarily due to:
•A $0.9 million decrease from Surface Protection associated with lower sales related to previously disclosed customer product transitions ($1.5 million), competitive pricing pressures for products unrelated to the customer product transitions ($1.4 million) and higher freight expense ($0.2 million), partially offset by higher volume, favorable mix ($1.0 million) and the pass-through lag associated with resin costs (benefit of $0.6 million in the first quarter of 2022 vs. charge of $0.5 million in the first quarter of 2021); and
•A $0.7 million increase from overwrap films primarily related to a benefit from the pass-through lag associated with resin costs (benefit of $0.3 million in the first quarter of 2022 versus a charge of $0.3 million in the first quarter of 2021) and favorable selling, general and administrative expenses ($0.4 million), partially offset by unfavorable mix ($0.2 million).
R efer to Item 3. Q uantitative and Qualitative Disclosures About Market Risk in this Form 10-Q f or additional information on resin prices.
Customer Product Transitions and Other Factors in Surface Protection
The Surface Protection component of PE Films supports manufacturers of optical and other specialty substrates used in flat panel display products. These films are primarily used by customers to protect components of displays in the manufacturing and transportation processes and then discarded.
The Company previously reported the risk that a portion of its film products used in surface protection applications would be made obsolete by customer product transitions to less costly alternative processes or materials. The Company estimates that these transitions, which principally relate to one customer, adversely impacted pre-tax income from continuing operations as reported under GAAP and EBITDA from ongoing operations for PE Films by $14.8 million during 2021 versus 2020. A total decline of $7 million in pre-tax income from continuing operations as reported under GAAP and EBITDA from ongoing operations due to the transitions is expected in 2022 versus 2021, at which time the transitions are expected to be complete.
The Surface Protection business is also experiencing competitive pricing pressures, unrelated to the customer product transitions, that are expected to adversely impact pre-tax income from continuing operations as reported under GAAP and
23

EBITDA from ongoing operations by approximately $6 million for full year 2022 versus 2021. To offset the expected adverse impact of the customer transitions and pricing pressures, the Company is aggressively pursuing and making progress in generating contribution from sales of new surface protection products, applications and customers and driving production efficiencies and cost savings. Annual contribution to pre-tax income from continuing operations as reported under GAAP and EBITDA from ongoing operations for PE Films from sales of products unrelated to previously disclosed customer product transitions increased $7 million for the two-year period ended December 31, 2021, which excludes the impact of resin pass-through lag but includes the adverse impact of customer inventory corrections, customer production slowdowns associated with COVID-19-related factors, and a slowdown in the television market in the fourth quarter of 2021.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for PE Films are projected to be $5 million in 2022, including $2 million for productivity projects and $3 million for capital expenditures required to support continuity of current operations. Depreciation expense is projected to be $7 million in 2022. There is no amortization expense for PE Films.
Flexible Packaging Films
A summary of results for Flexible Packaging Films is provided below:

|  |  |  |  | Three Months Ended |  | Favorable/ (Unfavorable) % Change
(In thousands, except percentages) |  |  | March 31, |
|  |  |  | 2022 |  | 2021 |
Sales volume (lbs) |  |  |  |  |  |  | 26,005 |  |  | 27,408 |  |  | (5.1)%
Net sales |  |  |  |  |  |  | $ | 39,244 |  |  | $ | 32,521 |  |  | 20.7%
Ongoing operations: |  |  |  |  |  |  |  |  |  |  |
EBITDA |  |  |  |  |  |  | $ | 5,035 |  |  | $ | 9,623 |  |  | (47.7)%
Depreciation & amortization |  |  |  |  |  |  | (550) |  |  | (466) |  |  | (18.0)%
EBIT* |  |  |  |  |  |  | $ | 4,485 |  |  | $ | 9,157 |  |  | (51.0)%
Capital expenditures |  |  |  |  |  |  | $ | 1,545 |  |  | $ | 1,271 |  |  |
* See the table in Note 10 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP.

First Quarter 2022 Results vs. First Quarter 2021 Results
Sales volume declined by 5.1% during the first quarter of 2022 versus the first quarter of 2021, which reflected the surge in pandemic-related demand. Net sales in the first quarter of 2022 increased 20.7% compared to the first quarter of 2021, primarily due to higher selling prices from the pass-through of higher resin costs and favorable product mix, partially offset by lower sales volume.
EBITDA from ongoing operations in the first quarter of 2022 decreased by $4.6 million versus the first quarter of 2021 primarily due to:
•Higher raw material costs ($6.0 million), higher variable costs ($1.6 million) and lower sales volume ($0.8 million), partially offset by higher selling prices ($4.9 million) from the pass-through of higher resin costs, favorable absorption of fixed costs ($0.4 million) and favorable product mix ($0.3 million);
•Net unfavorable foreign currency translation of Real-denominated operating costs ($0.3 million); and
•Foreign currency transaction losses ($0.9 million) in the first quarter of 2022 compared to foreign currency transaction gains ($0.4 million) in the first quarter of 2021.
Refer to Item 3. Quantitative and Qualitative Disclosures About Market Risk in this Form 10-Q f or additional information on polyester fiber and component price trends.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for Flexible Packaging Films are projected to be $8 million in 2022, including $4 million for new capacity for value-added products and productivity projects and $4 million for capital expenditures required to support continuity of current operations. Depreciation expense is projected to be $2 million in 2022. Amortization expense is projected to be $0.4 million in 2022.
Corporate Expenses, Interest & Other
Corporate expenses, net in the first three months of 2022 remained consistent with the first three months of 2021 as lower stock-based compensation ($0.8 million) was substantially offset by higher professional fees associated with remediation
24

activities related to the Company's previously disclosed material weaknesses in internal control over financial reporting ($0.3 million), non-recurring 2021 transition service fee income, net of corporate costs associated with the divested Personal Care Films business ($0.3 million) and higher professional fees associated with business development activities ($0.1 million).
Interest expense of $0.8 million in the first three months of 2022 remained consistent with the first three months of 2021 as lower average debt levels were offset by higher average interest rates.
Pension expense under GAAP of $3.5 million in the first three months of 2022 remained consistent with the first three months of 2021. On February 10, 2022, Tredegar announced the initiation of a process to terminate and settle its frozen defined benefit pension plan, which could take up to 24 months to complete. In connection therewith, the Company borrowed funds under its revolving credit agreement and made a $50 million contribution to the pension plan (the “Special Contribution”) to reduce its underfunding and as part of a program within the pension plan to hedge or fix the expected future contributions that will be needed by the Company through the settlement process. The Company expects to realize income tax cash benefits on the Special Contribution of approximately $11 million in 2022. Administrative costs for the pension plan through the settlement process are estimated at $4 to $5 million.
Tredegar’s frozen defined benefit pension plan was underfunded on a GAAP basis by $69 million at December 31, 2021, comprised of investments at fair value of $245 million and a projected benefit obligation (“PBO”) of $314 million. GAAP accounting requires adjustment for changes in values of assets and the PBO only at the end of each year, even though these values change daily. The Company estimates that the Special Contribution and changes to the values of pension plan assets and liabilities resulted in a decrease in the underfunding on a GAAP basis from $69 million at December 31, 2021 to approximately $13 million at March 31, 2022. The ultimate settlement benefit obligation may differ from the PBO, depending on market factors for buyers of pension obligations at the time of settlement.
Prior to the Special Contribution, GAAP pension expense was a reasonable proxy for the Company’s required minimum cash contribution to the pension plan. The Company estimates that, with the Special Contribution, there will be no required minimum cash contributions until final settlement. Pension expense under GAAP is projected to be approximately $14 million in 2022, which is mainly comprised of non-cash amortization of deferred net actuarial losses reflected in the Company’s shareholders’ equity as accumulated other comprehensive losses. Beginning in 2022, and consistent with no expected required minimum cash contributions, no pension expense is included in calculating earnings before interest, taxes, depreciation and amortization as defined in the Company’s revolving credit agreement.
Net capitalization and other credit measures are provided in Liquidity and Capital Resources below.
Liquidity and Capital Resources
The Company continues to focus on improving working capital management. Measures such as days sales outstanding (“DSO”), days inventory outstanding (“DIO”) and days payables outstanding (“DPO”) are used to evaluate changes in working capital. Changes in operating assets and liabilities from continuing operations from December 31, 2021 to March 31, 2022 are summarized below. Cash flows for discontinued operations have not been separately disclosed in the condensed consolidated statements of cash flows.
•Accounts and other receivables increased $26.2 million (25.4%).
◦Accounts and other receivables in Aluminum Extrusions increased by $20.1 million primarily due to an increase in average selling prices to cover significantly higher aluminum raw material costs and higher operating costs, partially offset by lower sales volume. DSO (represents trailing 12 months net sales divided by a rolling 12-month average of accounts and other receivables balances) was approximately 48.2 days for the 12 months ended March 31, 2022 and 47.6 days for the 12 months ended December 31, 2021.
◦Accounts and other receivables in PE Films increased by $1.9 million due to higher volume in Surface Protection and the timing of cash receipts. DSO was approximately 27.9 days for the 12 months ended March 31, 2022 and 28.5 days for the 12 months ended December 31, 2021.
◦Accounts and other receivables in Flexible Packaging Films increased by $4.3 million primarily due to higher selling prices from the pass-through of higher resin costs and favorable product mix, partially offset by lower sales volume. DSO was approximately 41.4 days for the 12 months ended March 31, 2022 and 40.0 days for the 12 months ended December 31, 2021.
•Inventories increased $16.0 million (18.1%).
◦Inventories in Aluminum Extrusions increased by $8.1 million due to higher average aluminum prices and the impact of COVID-19-related operational and production inefficiencies on the timing of shipments. DIO (represents trailing 12 months costs of goods sold calculated on a first-in first-out basis divided by a rolling 12-month average of inventory balances calculated on the first-in first-out basis) was approximately 43.9 days for the 12 months ended March 31, 2022 and 41.4 days for the 12 months ended December 31, 2021.
25

◦Inventories in PE Films increased $1.2 million due to higher planned raw material levels. DIO (represents trailing 12 months costs of goods sold calculated on a first-in first-out basis divided by a rolling 12-month average of inventory balances calculated on the first-in first-out basis) was approximately 59.2 days for the 12 months ended March 31, 2022 and 62.8 days for the 12 months ended December 31, 2021.
◦Inventories in Flexible Packaging Films increased by $6.7 million primarily due to the impact of higher average resin prices on raw materials and higher finished good levels due to lower than anticipated sales demand. DIO was approximately 95.0 days for the 12 months ended March 31, 2022 and 93.1 days for the 12 months ended December 31, 2021.
•Net property, plant and equipment increased $2.2 million primarily due to capital expenditures of $4.7 million and a change in the value of the U.S. dollar relative to foreign currencies (an increase of approximately $3.5 million), partially offset by depreciation expense of $5.8 million.
•Identifiable intangible assets, net decreased by $0.5 million (3.7%) due to amortization expense.
•Deferred income tax assets decreased $4.3 million during the first quarter of 2022 compared to December 31, 2021 primarily due to changes in other comprehensive income and the projected utilization of foreign tax credits partially offset by the change in the deferred tax liability as a result of the implementation of new U.S. tax regulations associated with foreign tax credits published by the U.S. Treasury and Internal Revenue Service on January 4, 2022. See Note 9 for additional information.
•Accounts payable increased $20.8 million (16.8%).
◦Accounts payable in Aluminum Extrusions increased by $15.7 million primarily due to higher average aluminum prices. DPO (represents trailing 12 months costs of goods sold calculated on a first-in first-out basis divided by a rolling 12-month average of accounts payable balances) was approximately 61.0 days for the 12 months ended March 31, 2022 and 60.1 days for the 12 months ended December 31, 2021.
◦Accounts payable in PE Films increased by $2.8 million primarily due to higher resin costs related to raw material purchases. DPO was approximately 47.0 days for the 12 months ended March 31, 2022 and 44.0 days for the 12 months ended December 31, 2021.
◦Accounts payable in Flexible Packaging Films increased $3.0 million due to higher resin costs related to raw material purchases and the impact from the change in the U.S. dollar value of currencies related to operations outside of the U.S. DPO was approximately 69.2 days for the 12 months ended March 31, 2022 and 68.2 days for the 12 months ended December 31, 2021.
Net cash used in operating activities was $54.7 million in the first three months of 2022 compared to net cash provided by operating activities of $9.9 million in the first three months of 2021. The change in operating activities is primarily due to the Special Contribution ($50 million) to the pension plan and lower net working capital ($16.0 million).
Net cash used in investing activities decreased during the first three months of 2022 compared to the first three months of 2021 due to lower capital expenditure spending ($0.2 million).
Net cash provided by financing activities of $53.8 million in the first three months of 2022, compared to $5.9 million in the first three months of 2021, increased primarily due to higher net borrowings ($49.3 million) under the Credit Agreement (as defined below) to fund the $50 million Special Contribution to the pension plan.
The Company believes that existing borrowing availability, current cash balances and cash flow from operations will be sufficient to satisfy short term material cash requirements related to working capital, capital expenditure, debt repayments and dividend requirements for at least the next twelve months. In the longer term, liquidity will depend on many factors, including results of operations, the timing and extent of capital expenditures, changes in operating plans, or other events that would cause the Company to seek additional financing in future periods.
At March 31, 2022, the Company had cash and cash equivalents of $25.6 million, including cash and cash equivalents held by locations outside the U.S. of $8.4 million.
Tredegar has a five-year secured revolving credit agreement (the “Credit Agreement”) providing for aggregate borrowings in an amount of $375 million, which matures in June 2024.
26

Net capitalization and indebtedness as defined under the Credit Agreement as of March 31, 2022 were as follows:

Net Capitalization and Indebtedness as of March 31, 2022
(In thousands)
Net capitalization: |
Cash and cash equivalents | $ | 25,648 |
Debt: |
Credit Agreement | 131,250 |
Debt, net of cash and cash equivalents | 105,602 |
Shareholders’ equity | 211,868 |
Net capitalization | $ | 317,470 |
Indebtedness as defined in Credit Agreement: |
Total debt | $ | 131,250 |
Indebtedness | $ | 131,250 |

Borrowings under the Credit Agreement bear an interest rate of LIBOR plus a credit spread and commitment fees charged on the unused amount under the Credit Agreement at various indebtedness-to-Credit EBITDA levels as follows:

Pricing Under The Credit Agreement (Basis Points)
Indebtedness-to-Credit EBITDA Ratio | Credit Spread Over LIBOR | Commitment Fee
> 3.5x but <= 4.0x | 200.0 |  | 40 |
> 3.0x but <= 3.5x | 187.5 |  | 35 |
> 2.0x but <= 3.0x | 175.0 |  | 30 |
> 1.0x but <= 2.0x | 162.5 |  | 25 |
<= 1.0x | 150.0 |  | 20 |

At March 31, 2022, the interest rate on debt under the Credit Agreement existing at that date was priced at one-month LIBOR plus the applicable credit spread of 150.0 basis points.
The most restrictive covenants in the Credit Agreement include:
•Maximum indebtedness-to-Credit EBITDA (“Leverage Ratio”) of 4.00x;
•Minimum Credit EBITDA-to-interest expense of 3.00x; and
•Maximum aggregate distributions to shareholders over the remaining term of the Credit Agreement of $75 million; provided, that if the Leverage Ratio of equal to or greater than 3.00x, a limitation on such payments for the succeeding quarter at the greater of (i) $4.75 million and (ii) 50% of consolidated net income for the most recent fiscal quarter.
The Credit Agreement is secured by substantially all of the Company’s and its domestic subsidiaries’ assets, including equity in certain material first-tier foreign subsidiaries. At March 31, 2022, based upon the most restrictive covenant within the Credit Agreement, available credit under the Credit Agreement was approximately $244 million. Total debt outstanding was $131 million and $73 million as of March 31, 2022 and December 31, 2021, respectively.
Credit EBITDA is not intended to represent net income (loss) or cash flow from operations as defined by GAAP and should not be considered as an alternative to either net income (loss) or to cash flow. The computations of Credit EBITDA and the leverage ratio and interest coverage ratio as defined in the Credit Agreement are presented below.
27

Computations of Credit EBITDA and Leverage Ratio and Interest Coverage Ratio as Defined in the Credit Agreement Along with Related Most Restrictive Covenants as of and for the Twelve Months Ended March 31, 2022 (In Thousands)
Computation of Credit EBITDA for the twelve months ended March 31, 2022:
Net income (loss) | $ | 65,217 |
Plus: |
After-tax losses related to discontinued operations | (441) |
Total income tax expense for continuing operations | 6,965 |
Interest expense | 3,350 |
Depreciation and amortization expense for continuing operations | 24,090 |
All non-cash losses and expenses, plus cash losses and expenses not to exceed $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings (cash-related of $9,753) | 10,161 |
Charges related to stock option grants and awards accounted for under the fair value-based method | 2,658 |
Losses related to the application of the equity method of accounting | — |
Losses related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting | — |
Minus: |
After-tax income related to discontinued operations | — |
Total income tax benefits for continuing operations | — |
Interest income | (95) |
All non-cash gains and income, plus cash gains and income in excess of $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings | (3,859) |
Income related to changes in estimates for stock option grants and awards accounted for under the fair value-based method | — |
Income related to the application of the equity method of accounting | — |
Income related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting | (12,062) |
Plus cash dividends declared on investments in an amount not to exceed $10,000 for such period | — |
Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset dispositions | — |
Plus or minus, as applicable, pro forma EBITDA adjustments to pension expense associated with the early payment of pension obligations | 13,950 |
Credit EBITDA as defined in Credit Agreement | $ | 109,934 |
Computations of leverage and interest coverage ratios as defined in the Credit Agreement at March 31, 2022:
Leverage ratio (indebtedness-to-Credit EBITDA) | 1.19x
Interest coverage ratio (Credit EBITDA-to-interest expense) | 32.82x
Most restrictive covenants as defined in the Credit Agreement: |
Available balance of maximum permitted aggregate amount of dividends that can be paid by Tredegar during the remaining term of the Credit Agreement ($75,000 minus $24,246 of dividends paid after December 1, 2020) | 50,754
Maximum leverage ratio permitted | 4.00x
Minimum interest coverage ratio permitted | 3.00x

Tredegar was in compliance with all of its debt covenants as of March 31, 2022. Noncompliance with any of the debt covenants may have a material adverse effect on its financial condition or liquidity, in the event such noncompliance cannot be cured or should the Company be unable to obtain a waiver from the lenders. Renegotiation of the covenant through an amendment to the Credit Agreement may effectively cure the noncompliance, but may have an effect on its financial condition or liquidity depending upon how the covenant is renegotiated.
28

Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Tredegar has exposure to the volatility of interest rates, polyethylene and polypropylene resin prices, Terephthalic Acid (“PTA”) and Monoethylene Glycol (“MEG”) prices, aluminum ingot and scrap prices, energy prices, foreign currencies and emerging markets. See Liquidity and Capital Resources above regarding interest rate exposures related to borrowings under the Credit Agreement.
Profit margins in Aluminum Extrusions are sensitive to fluctuations in aluminum ingot and scrap prices as well as natural gas prices (natural gas is the principal energy source used to operate its casting furnaces). Changes in polyethylene resin prices and the timing of those changes could have a significant impact on profit margins in PE Films. Changes in polyester resin, PTA and MEG prices, and the timing of those changes, could have a significant impact on profit margins in Flexible Packaging Films. There is no assurance of the Company’s ability to pass through higher raw material and energy costs to its customers.
In the normal course of business, Aluminum Extrusions enters into fixed-price forward sales contracts with certain customers for the sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge its exposure to aluminum price volatility (see the chart below) under these fixed-price arrangements, which generally have a duration of not more than 12 months, the Company enters into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled deliveries. See Note 8 for additional information.
The volatility of quarterly average aluminum prices is shown in the chart below.

Source: Quarterly averages computed by the Company using daily Midwest average prices provided by Platts.

In certain situations, Aluminum Extrusions has index-based pass-through raw material cost arrangements with customers. However, under certain agreements, changes in aluminum prices are not passed through for a period of 90 days.
The volatility of quarterly average natural gas prices is shown in the chart below.
29

Source: Quarterly averages computed by Tredegar using monthly NYMEX settlement prices.

The volatility of average quarterly prices of polyethylene resin in the U.S. (a primary raw material for PE Films) is shown in the chart below.

Source: Quarterly averages computed by Tredegar using monthly data provided by IHS, Inc. In February 2020, IHS reflected a 32 cents per pound non-market adjustment based on their estimate of the growth of discounts in prior periods. The 4th quarter 2019 average rate of $0.51 per pound is shown on a pro forma basis as if the non-market adjustment was made in the fourth quarter of 2019.

The price of resin is driven by several factors, including supply and demand and the price of oil, ethylene and natural gas. Selling prices to customers are set considering numerous factors, including the expected volatility of resin prices. PE Films has index-based pass-through raw material cost arrangements with customers. However, under certain agreements, changes in resin prices are not passed through for a period of 90 days. In response to unprecedented cost increases and supply issues for polyethylene and polypropylene resin, Tredegar Surface Protection implemented a quarterly resin cost pass-through mechanism, effective July 1, 2021, for all products and customers not previously covered by such arrangements. Pricing on the remainder of the business is based upon raw material costs and supply/demand dynamics within the markets that the Company competes.
Polyester resins, MEG and PTA used in flexible packaging films produced in Brazil are primarily purchased domestically, with other sources available mostly from Asia and the U.S. Given the nature of these products as commodities, pricing is derived from Asian pricing indexes. The volatility of the average quarterly prices for polyester fibers in Asia, which is representative of polyester resin (a primary raw material for Flexible Packaging Films) pricing trends, is shown in the chart below:
30

Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.

The volatility of average quarterly prices of PTA and MEG in Asia (raw materials used in the production of polyester resins produced by Flexible Packaging Films) is shown in the chart below:

Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.

Tredegar attempts to match the pricing and cost of its products in the same currency and generally views the volatility of foreign currencies and the corresponding impact on earnings and cash flow as part of the overall risk of operating in a global environment (for additional information, see trends for the Brazilian Real and Chinese Yuan in the charts on the following page). Exports from the U.S. are generally denominated in U.S. Dollars. The Company’s foreign currency exposure on income from continuing foreign operations relates to the Chinese Yuan and the Brazilian Real.
PE Films is generally able to match the currency of its sales and costs for its product lines. For flexible packaging films produced in Brazil, selling prices and key raw material costs are principally determined in U.S. Dollars and are impacted by local economic conditions and local and global competitive dynamics. Flexible Packaging Films is exposed to foreign exchange translation risk (its functional currency is the Brazilian Real) because almost 90% of the sales of Flexible Packaging Films business unit in Brazil (“Terphane Ltda.”) and substantially all of its related raw material costs are quoted or priced in U.S. Dollars while its variable conversion, fixed conversion and sales, general and administrative costs before depreciation & amortization (collectively “Terphane Ltda. Operating Costs”) are quoted or priced in Brazilian Real. This mismatch, together
31

with a variety of economic variables impacting currency exchange rates, causes volatility that could negatively or positively impact EBITDA from ongoing operations for Flexible Packaging Films.
The Company estimates annual net costs of R$150 million for the net mismatch translation exposure between Terphane Ltda.’s U.S. Dollar quoted or priced sales and raw material costs and underlying Brazilian Real quoted or priced Terphane Ltda. Operating Costs. Terphane Ltda. has outstanding foreign exchange average forward rate contracts to purchase Brazilian Real and sell U.S. Dollars to hedge its exposure. See Note 8 for more information on outstanding hedging contracts and this hedging program.
Tredegar estimates that the impact on PE Films EBITDA from ongoing operations from the change in the value of foreign currencies relative to the U.S. Dollar was flat in the first quarter of 2022 compared with the first quarter of 2021.
Trends for the Brazilian Real and Chinese Yuan exchange rates relative to the U.S. Dollar are shown in the chart below.

Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.

Item 4. Controls and Procedures.
On November 1, 2018, the Company filed a Current Report on Form 8-K (the “November 2018 Form 8-K”) to disclose deficiencies in internal control over financial reporting. For further information, see the November 2018 Form 8-K and Item 4. “Controls and Procedures” of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2018.
Evaluation of Disclosure Controls and Procedures
In connection with the preparation of this Form 10-Q, pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company carried out an evaluation with the participation of its management, including its Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined under Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2022.
Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that, because of the material weaknesses in internal control over financial reporting discussed below, the Company’s disclosure controls and procedures were not effective as of March 31, 2022, to ensure: (i) that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and (ii) that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. The Company’s internal control over financial reporting is a process designed by or under the supervision of the Company’s Chief Executive Officer and Chief Financial Officer, and overseen by the Board of Directors, to provide reasonable assurance regarding the reliability of financial
32

reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes policies and procedures that:
•Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets;
•Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company’s receipts and expenditures are being made only in accordance with the authorization of its management and directors; and
•Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of the Company’s consolidated financial statements would be prevented or detected. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.
Management conducted an evaluation of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2021 using the criteria in Internal Control - Integrated Framework 2013 issued by the Committee of Sponsoring Organizations of the Treadway Commission (the “2013 COSO Framework”). As a result of this evaluation, management concluded, as disclosed in the 2021 Form 10-K, that the Company’s internal control over financial reporting was not effective as of December 31, 2021, because of the material weaknesses in internal control over financial reporting discussed below.
•Control Environment: The Company did not have a sufficient number of trained resources with assigned responsibility and accountability for the design, operation and documentation of internal control over financial reporting in accordance with the 2013 COSO Framework.
•Risk Assessment: The Company did not have an effective risk assessment process to identify and evaluate at a sufficient level of detail all relevant risks of material misstatement, including fraud risks.
•Information and Communication: The Company did not have an effective information and communication process that identified and assessed the source of and controls necessary to ensure the reliability of information used in financial reporting and that communicates relevant information about roles and responsibilities for internal control over financial reporting.
•Monitoring Activities: The Company did not have effective monitoring activities to assess the operation of internal control over financial reporting, including the continued appropriateness of control design and level of documentation maintained to support control effectiveness.
•Control Activities: As a consequence of the material weaknesses described above, internal control deficiencies related to the design and operation of process-level controls and general information technology controls were determined to be pervasive throughout the Company’s processes.
While these material weaknesses did not result in material misstatements of the Company’s consolidated financial statements as of and for the year ended December 31, 2021, these material weaknesses create a reasonable possibility that a material misstatement of account balances or disclosures in annual or interim consolidated financial statements may not be prevented or detected in a timely manner. Accordingly, the Company concluded that the deficiencies represent material weaknesses in its internal control over financial reporting and its internal control over financial reporting was not effective as of December 31, 2021.
The Company’s independent registered public accounting firm, KPMG LLP, which audited the 2021 consolidated financial statements included in the 2021 Form 10-K, expressed an adverse opinion on the operating effectiveness of the Company's internal control over financial reporting as of December 31, 2021.
Remediation Plan and Efforts to Address the Previously Identified Material Weaknesses
To remediate the material weaknesses described above, the Company, with the oversight of the Audit Committee of the Board of Directors (the “Audit Committee”), has been pursuing the six remediation steps as originally identified in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The Company’s remediation plan was designed with the assistance of management’s outside consultant, an internationally recognized accounting firm. In the first quarter of 2022, the Company began to implement new and revised internal controls over financial reporting designed as part of management’s remediation plan across the organization. The Company continues to work with its outside consultant to assist
33

in completing the remaining steps in the remediation plan and believes that its remediation plan will be sufficient to remediate the identified material weaknesses and strengthen its internal control over financial reporting. As the Company continues to evaluate, implement and works to improve, its internal control over financial reporting, management may determine that additional measures to address control deficiencies or modifications to the remediation plan are necessary.
Through the first quarter of 2022, the Company has completed certain steps in its remediation plan, including:
•for certain processes, developed new and revised existing process narratives and identified risks of material misstatement inherent to those processes;
•developed new controls and revised the design of existing controls for a significant number of relevant key controls to mitigate the aforementioned risks, inclusive of general information technology controls and entity-level controls;
•conducted initial organization-wide training sessions with all control owners;
•increased resources in the Company’s internal audit function and created and staffed a controls compliance group charged with monitoring and facilitating compliance with the Company’s responsibilities under the Sarbanes Oxley Act of 2002 (“SOX”);
•implemented a software solution to assist in monitoring and documenting compliance with SOX;
•migrated certain components of a legacy information technology system onto a common information technology environment; and
•implemented new and revised internal controls over financial reporting for certain processes and information technology environments.
The following remaining activities are scheduled for completion in the first half of 2022 in anticipation of conducting management’s testing that will begin in the first half of 2022 in support of issuing management’s assessment of internal control over financial reporting as of December 31, 2022:
•completion of the identification of risks arising from inappropriate segregation of duties and fraud risks;
•completion of risk assessment and control design for the remaining populations of processes and controls;
•implementation of controls across the remaining processes and information technology environments; and
•ongoing training with control owners, as necessary.
The Company continues to monitor the impact of employee turnover, the COVID-19 pandemic and other external factors on its remediation plan and its assessment of internal control over financial reporting. The material weaknesses cannot be considered remediated until the applicable controls have operated for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. The Company cannot assure you when it will remediate the identified material weaknesses, nor can it be certain whether additional actions will be required. Moreover, the Company cannot assure you that additional material weaknesses will not arise in the future.
Changes in Internal Control Over Financial Reporting
The Company is in the process of making certain changes in its internal controls to remediate the material weaknesses as described above. The execution of the material aspects of this remediation plan began in the second quarter of 2019. Except as noted above with respect to the completion of certain steps in the remediation plan and implementation of certain new and revised internal controls over financial reporting, there has been no change in the Company’s internal control over financial reporting during the quarter ended March 31, 2022, that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act).
PART II - OTHER INFORMATION
Item 1A. Risk Factors.
As disclosed in “Item 1A. Risk Factors” in the 2021 Form 10-K, there are a number of risks and uncertainties that can have a material effect on the operating results of our businesses and our financial condition. There are no additional material updates or changes to our risk factors previously disclosed in the 2021 Form 10-K.
34

Item 6. Exhibits.

31.1 |  | Certification of President and Chief Executive Officer of Tredegar Corporation, pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 |  | Certification of Executive Vice President and Chief Financial Officer of Tredegar Corporation, pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 |  | Certification of President and Chief Executive Officer of Tredegar Corporation, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 |  | Certification of Executive Vice President and Chief Financial Officer of Tredegar Corporation, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101 |  | XBRL Instance Document and Related Items.
104 |  | Cover Page Interactive Data File (formatted in iXBRL and contained in Exhibit 101).

35

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  |  |  | Tredegar Corporation
|  |  |  | (Registrant)
Date: |  | May 9, 2022 |  | /s/ John M. Steitz
|  |  |  | John M. Steitz
|  |  |  | President and Chief Executive Officer
|  |  |  | (Principal Executive Officer)
Date: |  | May 9, 2022 |  | /s/ D. Andrew Edwards
|  |  |  | D. Andrew Edwards
|  |  |  | Executive Vice President and Chief Financial Officer
|  |  |  | (Principal Financial Officer)
Date: |  | May 9, 2022 |  | /s/ Frasier W. Brickhouse, II
|  |  |  | Frasier W. Brickhouse, II
|  |  |  | Corporate Treasurer and Controller
|  |  |  | (Principal Accounting Officer)